Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_adsipsc_promoter_p_PM_12_63_8			2	0.4	1.68E-04	RNF20, PTPRU	negative regulation of cell migration [BP]
CG_adsipsc_promoter_p_PM_12_458_14			2	0.4	1.51E-05	CSK	negative regulation of Golgi to plasma membrane protein transport [BP], negative regulation of low-density lipoprotein particle clearance [BP], regulation of Fc receptor mediated stimulatory signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_207_6			3	0.6	7.98E-05	ADARB1	negative regulation of protein kinase activity by regulation of protein phosphorylation [BP], double-stranded RNA adenosine deaminase activity [MF], adenosine to inosine editing [BP]
CG_adsipsc_promoter_p_PM_12_65_9			2	0.4	7.03E-05	ST3GAL3	N-acetyllactosaminide alpha-2,3-sialyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_392_10			5	0.8	1.89E-04	FN3K, P2RX2, ROMO1, ZC3H12A	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], fructoselysine metabolic process [BP], fructosamine-3-kinase activity [MF], positive regulation of reactive oxygen species metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_54_14			3	0.6	3.70E-05	FAHD1, MRAP, FMN2, OXT	positive regulation of hindgut contraction [BP], meiotic chromosome movement towards spindle pole [BP], type 5 melanocortin receptor binding [MF], oxytocin receptor binding [MF], neurohypophyseal hormone activity [MF], positive regulation of female receptivity [BP], acylpyruvate hydrolase activity [MF], fumarylpyruvate hydrolase activity [MF], acetylpyruvate hydrolase activity [MF], positive regulation of norepinephrine secretion [BP], corticotropin hormone receptor binding [MF]
CG_adsipsc_promoter_p_PM_14_4_35			4	0.6	8.55E-05	NUDT2, KIAA1279, GTPBP5, SETD8, SLMO1, MTHFD1	regulation of DNA damage response, signal transduction by p53 class mediator [BP], mitochondrion [CC]
CG_adsipsc_promoter_p_PM_12_56_12			2	0.4	4.41E-04	TNFRSF1B, ZRSR2	pre-mRNA 3'-splice site binding [MF], RNA destabilization [BP]
CG_adsipsc_promoter_p_PM_14_97_4			1	0.2	7.96E-05	NANS	N-acylneuraminate-9-phosphate synthase activity [MF], N-acetylneuraminate synthase activity [MF]
CG_adsipsc_promoter_p_PM_12_26_5			2	0.4	7.04E-05	TNFRSF11A	circadian temperature homeostasis [BP]
CG_adsipsc_promoter_p_PM_12_439_5			1	0.2	2.82E-05	ALDH3A2	medium-chain-aldehyde dehydrogenase activity [MF], phytol metabolic process [BP], sesquiterpenoid metabolic process [BP], long-chain-aldehyde dehydrogenase activity [MF], long-chain-alcohol oxidase activity [MF]
CG_adsipsc_promoter_p_PM_12_322_9			2	0.4	1.20E-04	ACSF3, BTD	malonate catabolic process [BP], biotinidase activity [MF], malonyl-CoA synthetase activity [MF]
CG_adsipsc_promoter_p_PM_12_325_17			3	0.6	1.44E-04	SCIN, FMNL1	actin filament severing [BP]
CG_adsipsc_promoter_p_PM_12_504_16			5	0.8	1.88E-05	IREB2, ETFDH, B3GNT5, PNP	NAD biosynthesis via nicotinamide riboside salvage pathway [BP], beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [MF], purine-nucleoside phosphorylase activity [MF], lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [MF], inosine catabolic process [BP], lipopolysaccharide N-acetylglucosaminyltransferase activity [MF], nicotinamide riboside catabolic process [BP], 4 iron, 4 sulfur cluster binding [MF], oxidoreductase activity, oxidizing metal ions with flavin as acceptor [MF]
CG_adsipsc_promoter_p_PM_18_18_30			2	0.4	5.17E-05	D2HGDH, STK11, VCL, AGBL5, CPA5, STAT5A, AEBP1, ING1, OGDH	protein complex [CC], metallocarboxypeptidase activity [MF], 2-oxoglutarate metabolic process [BP], cell cycle [BP]
CG_adsipsc_promoter_p_PM_12_30_11			3	0.6	9.51E-05	ACSL3	positive regulation of Golgi to plasma membrane protein transport [BP], positive regulation of phosphatidylcholine biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_20_8			1	0.2	1.63E-05	DNAJA3	interferon-gamma receptor binding [MF]
CG_adsipsc_promoter_p_PM_18_15_55			5	0.8	7.11E-05	SRP72, EXOSC2	7S RNA binding [MF]
CG_adsipsc_promoter_p_PM_12_480_16			2	0.4	7.30E-05	CACNA1E, PPP1R26, CACNA1G, LMTK2	protein phosphatase inhibitor activity [MF], voltage-gated calcium channel activity [MF], voltage-gated calcium channel complex [CC]
CG_adsipsc_promoter_p_PM_12_248_11			2	0.4	1.98E-05	URM1	tRNA thio-modification [BP]
CG_adsipsc_promoter_p_PM_12_45_10			1	0.2	1.07E-04	TTF2, TSC2, CRIPAK, CDK5R2, PAFAH1B1	transcription elongation factor complex [CC], layer formation in cerebral cortex [BP], negative regulation of protein kinase activity [BP], astral microtubule [CC], establishment of centrosome localization [BP]
CG_adsipsc_promoter_p_PM_12_436_8			2	0.4	2.19E-04	DSP, SLC22A1	acetylcholine transmembrane transporter activity [MF], ventricular compact myocardium morphogenesis [BP], norepinephrine transmembrane transporter activity [MF]
CG_adsipsc_promoter_p_PM_12_419_7			2	0.4	2.54E-04	AFTPH	AP-1 adaptor complex [CC]
CG_adsipsc_promoter_p_PM_12_361_8			1	0.2	6.16E-05	FNDC1, PCYOX1L	positive regulation of cardiac muscle cell apoptotic process [BP], prenylcysteine catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_179_7			1	0.2	2.52E-05	FAM20C, BTN3A2, ACSF3, DLD, XCL1	malonate catabolic process [BP], malonyl-CoA synthetase activity [MF], positive regulation of granzyme B production [BP], dihydrolipoyl dehydrogenase activity [MF], positive regulation of immunoglobulin production in mucosal tissue [BP], positive regulation of T-helper 1 cell cytokine production [BP], negative regulation of CD4-positive, alpha-beta T cell proliferation [BP], T cell mediated immunity [BP], dentinogenesis [BP], positive regulation of CD8-positive, alpha-beta T cell proliferation [BP], mature natural killer cell chemotaxis [BP], positive regulation of granzyme A production [BP], positive regulation of CD4-positive, alpha-beta T cell proliferation [BP], negative regulation of T-helper 1 cell activation [BP], osteoclast maturation [BP]
CG_adsipsc_promoter_p_PM_12_488_12			2	0.4	1.48E-04	NCKAP1L, PLCG2	B cell differentiation [BP], negative regulation of myosin-light-chain-phosphatase activity [BP], follicular B cell differentiation [BP], positive regulation of CD8-positive, alpha-beta T cell differentiation [BP], actin polymerization-dependent cell motility [BP], B cell receptor signaling pathway [BP], SCAR complex [CC]
CG_adsipsc_promoter_p_PM_12_399_10			2	0.4	1.68E-04	STUB1	regulation of glucocorticoid metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_413_16			2	0.4	4.87E-05	ZFPM1, HSD11B2, ARFGEF2, LBP	symmetric synapse [CC], transcriptional activation by promoter-enhancer looping [BP], positive regulation of respiratory burst involved in inflammatory response [BP], regulation of chemokine production [BP], leukocyte chemotaxis involved in inflammatory response [BP], negative regulation of mast cell differentiation [BP], 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [MF], axonemal microtubule [CC], regulation of blood volume by renal aldosterone [BP], positive regulation of tumor necrosis factor production [BP], mitral valve formation [BP], negative regulation of interleukin-4 biosynthetic process [BP], lipopolysaccharide transport [BP], tricuspid valve formation [BP]
CG_adsipsc_promoter_p_PM_12_323_15			3	0.6	3.41E-05	PPP6R3, PPP4R4	regulation of phosphoprotein phosphatase activity [BP], regulation of protein serine/threonine phosphatase activity [BP]
CG_adsipsc_promoter_p_PM_14_103_8			2	0.4	3.97E-05	CSNK1G2, ENOPH1, STK4, NME1, PINK1	magnesium ion binding [MF], acireductone synthase activity [MF], C3HC4-type RING finger domain binding [MF]
CG_adsipsc_promoter_p_PM_12_289_7			2	0.4	1.03E-04	BTN3A3, ICAM1, NLGN1, CD3E	immunological synapse [CC], cell adhesion molecule binding [MF], neurexin clustering [BP], positive regulation of synaptic vesicle endocytosis [BP], T cell antigen processing and presentation [BP], response to sulfur dioxide [BP], T cell mediated immunity [BP], cytoskeletal matrix organization at active zone [BP], heterophilic cell-cell adhesion [BP], positive regulation of synaptic vesicle exocytosis [BP]
CG_adsipsc_promoter_p_PM_12_218_10			1	0.2	3.44E-05	TCTN1	central nervous system interneuron axonogenesis [BP]
CG_adsipsc_promoter_p_PM_14_66_17			2	0.4	7.02E-05	TIMM17A, PMPCA, MFN2	protein targeting to mitochondrion [BP]
CG_adsipsc_promoter_p_PM_12_300_7			2	0.4	9.81E-05	MAPT, KTN1, NEK6	lipoprotein particle binding [MF], kinesin binding [MF]
CG_adsipsc_promoter_p_PM_12_367_8			1	0.2	3.96E-05	CPE	insulin processing [BP], transport vesicle membrane [CC]
CG_adsipsc_promoter_p_PM_12_134_9			1	0.2	1.17E-04	SOX8, ZAP70, HES1	oligodendrocyte differentiation [BP], negative regulation of stomach neuroendocrine cell differentiation [BP], metanephric nephron tubule morphogenesis [BP], negative regulation of pancreatic A cell differentiation [BP], positive regulation of gliogenesis [BP], N-box binding [MF], lateral inhibition [BP], ureteric bud morphogenesis [BP], positive regulation of mitotic cell cycle, embryonic [BP], T cell aggregation [BP]
CG_adsipsc_promoter_p_PM_12_178_13			4	0.6	5.53E-05	STS, CABYR	sperm fibrous sheath [CC], steryl-sulfatase activity [MF]
CG_adsipsc_promoter_p_PM_16_3_9			3	0.6	5.73E-05	GPAA1	tubulin binding [MF]
CG_adsipsc_promoter_p_PM_18_35_69			2	0.4	3.66E-05	SORBS3, UTRN, KAT6B, ING5	MOZ/MORF histone acetyltransferase complex [CC], vinculin binding [MF]
CG_adsipsc_promoter_p_PM_12_304_9			2	0.4	1.17E-04	DRAXIN, FCAR	commissural neuron differentiation in spinal cord [BP], IgA binding [MF]
CG_adsipsc_promoter_p_PM_12_176_8			2	0.4	4.29E-05	NKD1	positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade [BP], negative regulation of convergent extension involved in axis elongation [BP], regulation of cell motility involved in somitogenic axis elongation [BP]
CG_adsipsc_promoter_p_PM_12_442_11			3	0.6	4.44E-05	PRLH	prolactin-releasing peptide receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_185_14			2	0.4	1.06E-05	MYOCD, GAL3ST2	positive regulation of cardiac vascular smooth muscle cell differentiation [BP], galactosylceramide sulfotransferase activity [MF], regulation of cell growth by extracellular stimulus [BP], negative regulation of beta-amyloid clearance [BP], positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [BP], ductus arteriosus closure [BP], positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [BP], hepatic stellate cell activation [BP]
CG_adsipsc_promoter_p_PM_12_69_9			1	0.2	2.25E-04	BGN, AXL, GDF7	blood vessel remodeling [BP], roof plate formation [BP], positive regulation of tendon cell differentiation [BP]
CG_adsipsc_promoter_p_PM_12_499_9			2	0.4	3.48E-04	EGR1, KLF2, PRKCZ, PNP	T cell differentiation [BP], NAD biosynthesis via nicotinamide riboside salvage pathway [BP], long-term synaptic potentiation [BP], purine-nucleoside phosphorylase activity [MF], inosine catabolic process [BP], nicotinamide riboside catabolic process [BP], cellular response to interleukin-1 [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP], positive regulation of alpha-beta T cell differentiation [BP]
CG_adsipsc_promoter_p_PM_12_87_15			2	0.4	6.84E-05	LILRB1	negative regulation of osteoclast development [BP], HLA-A specific inhibitory MHC class I receptor activity [MF], negative regulation of interferon-beta secretion [BP], negative regulation of interleukin-10 secretion [BP], negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [BP], T cell proliferation involved in immune response [BP], negative regulation of dendritic cell apoptotic process [BP], HLA-B specific inhibitory MHC class I receptor activity [MF], positive regulation of cytolysis [BP], negative regulation of dendritic cell differentiation [BP], Fc receptor mediated inhibitory signaling pathway [BP], negative regulation of interleukin-12 secretion [BP], negative regulation of natural killer cell mediated cytotoxicity [BP], positive regulation of gamma-delta T cell activation involved in immune response [BP], negative regulation of transforming growth factor-beta secretion [BP], negative regulation of CD8-positive, alpha-beta T cell activation [BP], negative regulation of serotonin secretion [BP], negative regulation of T cell mediated cytotoxicity [BP]
CG_adsipsc_promoter_p_PM_14_5_12			4	0.6	1.56E-05	SHBG	primary spermatocyte growth [BP]
CG_adsipsc_promoter_p_PM_12_308_8			1	0.2	4.82E-05	POFUT1	peptide-O-fucosyltransferase activity [MF], protein O-linked fucosylation [BP]
CG_adsipsc_promoter_p_PM_12_212_12			2	0.4	3.40E-05	ALG1, GPX4, NAT1	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], arylamine N-acetyltransferase activity [MF], phospholipid-hydroperoxide glutathione peroxidase activity [MF]
CG_adsipsc_promoter_p_PM_16_7_21			2	0.2	4.27E-05	CYFIP1, ITSN1, WAC, SUDS3, ABI2, TRIM13	proline-rich region binding [MF], lamellipodium [CC], positive regulation of macroautophagy [BP], enzyme binding [MF]
CG_adsipsc_promoter_p_PM_16_1_155			5	1.0	6.04E-05	PRPF31, TBC1D22A, MAP2K1, RNF114, SGSM2, DIXDC1, CDC42, MAPK8IP3, CPXCR1	mitogen-activated protein kinase kinase kinase binding [MF], intracellular [CC], ribonucleoprotein complex binding [MF]
CG_adsipsc_promoter_p_PM_12_191_10			1	0.2	1.62E-04	GCAT	glycine C-acetyltransferase activity [MF], L-threonine catabolic process to glycine [BP]
CG_adsipsc_promoter_p_PM_12_221_9			1	0.2	1.67E-04	GSTO1, ALLC, APOC1, FPGS	tetrahydrofolylpolyglutamate synthase activity [MF], negative regulation of phosphatidylcholine catabolic process [BP], allantoicase activity [MF], allantoin catabolic process [BP], positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [BP]
CG_adsipsc_promoter_p_PM_12_440_13			3	0.6	9.29E-05	PARK7, SLC26A4, ACMSD, AOX1, CNTF	xanthine dehydrogenase activity [MF], aminocarboxymuconate-semialdehyde decarboxylase activity [MF], positive regulation of oxidative phosphorylation uncoupler activity [BP], negative regulation of neuron apoptotic process [BP], iodide transmembrane transporter activity [MF], aldehyde oxidase activity [MF]
CG_adsipsc_promoter_p_PM_18_34_83			4	0.8	4.49E-05	SLC2A4, ATP7A, POLI, FURIN, RAB27B	intracellular membrane-bounded organelle [CC], trans-Golgi network transport vesicle [CC]
CG_adsipsc_promoter_p_PM_20_24_84			1	0.2	4.36E-05	FADD, CASP8	death-inducing signaling complex [CC], CD95 death-inducing signaling complex [CC]
CG_adsipsc_promoter_p_PM_12_321_12			2	0.4	1.34E-04	MSX2	embryonic nail plate morphogenesis [BP], positive regulation of catagen [BP]
CG_adsipsc_promoter_p_PM_18_23_23			2	0.4	7.41E-05	RPS6KB1, RFC5, RAD9B, PSMD7, D2HGDH, PSMD11, RBM38, CCND1, CDKN3, SART1, SLC31A1, ATP7A, RPA1, STRADB, LCK, RIF1	response to DNA damage stimulus [BP], mitotic cell cycle G1/S transition DNA damage checkpoint [BP], S phase of mitotic cell cycle [BP], response to zinc ion [BP], cell cycle arrest [BP], cell cycle checkpoint [BP], copper ion transmembrane transporter activity [MF], G1/S transition of mitotic cell cycle [BP], DNA damage checkpoint [BP]
CG_adsipsc_promoter_p_PM_18_11_38			4	0.8	2.00E-05	KDM1A, ZNF205, RIPK1	positive regulation of reactive oxygen species metabolic process [BP], positive regulation of hydrogen peroxide biosynthetic process [BP], regulation of primitive erythrocyte differentiation [BP], regulation of ATP:ADP antiporter activity [BP], positive regulation of mitochondrial outer membrane permeabilization [BP]
CG_adsipsc_promoter_p_PM_12_140_20			2	0.4	3.57E-04	MPG	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF]
CG_adsipsc_promoter_p_PM_12_457_8			1	0.2	2.31E-04	ACADS	butyrate catabolic process [BP], butyryl-CoA dehydrogenase activity [MF]
CG_adsipsc_promoter_p_PM_12_74_12			2	0.4	1.05E-04	SMC2, LIMK2, PABPC3, HIST1H2AH, HNRNPAB	protein heterodimerization activity [MF], nucleotide binding [MF]
CG_adsipsc_promoter_p_PM_18_42_157			5	0.8	2.57E-05	SPTBN4, ARF6, RPTOR	axon hillock [CC], RNA polymerase III type 2 promoter DNA binding [MF], cell body fiber [CC], vesicle-mediated transport [BP], RNA polymerase III type 3 promoter DNA binding [MF], establishment of protein localization to plasma membrane [BP], TFIIIC-class transcription factor binding [MF], RNA polymerase III type 1 promoter DNA binding [MF]
CG_adsipsc_promoter_p_PM_14_79_29			10	1.0	4.90E-05	TTLL9, KLF5, MFN2, MFN1, TTLL10, THRAP3	tubulin-tyrosine ligase activity [MF], mitochondrial fusion [BP], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_p_PM_12_230_12			2	0.4	1.50E-04	RNF5, PUS1	pseudouridylate synthase activity [MF], ER-associated misfolded protein catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_89_14			3	0.6	7.93E-05	LRSAM1	ubiquitin-dependent endocytosis [BP]
CG_adsipsc_promoter_p_PM_12_146_13			1	0.2	1.26E-04	DCLRE1B	telomeric loop formation [BP], telomeric 3' overhang formation [BP]
CG_adsipsc_promoter_p_PM_14_106_10			1	0.2	7.08E-05	REST, DIO3, ALPL	negative regulation of amniotic stem cell differentiation [BP], negative regulation of dense core granule biogenesis [BP], thyroxine 5-deiodinase activity [MF], cementum mineralization [BP], negative regulation of mesenchymal stem cell differentiation [BP], hormone biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_334_10			1	0.2	1.86E-04	SLC24A3, IGFBP2	calcium, potassium:sodium antiporter activity [MF], insulin-like growth factor II binding [MF]
CG_adsipsc_promoter_p_PM_12_61_9			2	0.4	4.55E-05	PAOX	N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [MF], spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [MF], putrescine catabolic process [BP], positive regulation of spermidine biosynthetic process [BP], polyamine oxidase activity [MF], putrescine biosynthetic process [BP], spermine catabolic process [BP], spermidine catabolic process [BP], spermine:oxygen oxidoreductase (spermidine-forming) activity [MF]
CG_adsipsc_promoter_p_PM_14_127_15			2	0.4	3.14E-05	PEA15, TNF, P2RX4, EIF2B5	positive regulation of translational initiation [BP], positive regulation of nitric oxide biosynthetic process [BP], negative regulation of glucose import [BP]
CG_adsipsc_promoter_p_PM_12_109_14			2	0.4	1.36E-04	CD2, PTGDR	positive regulation of myeloid dendritic cell activation [BP], cellular response to prostaglandin D stimulus [BP]
CG_adsipsc_promoter_p_PM_12_200_9			2	0.4	4.32E-05	CHAF1A, NPY5R, RBBP8	generation of ovulation cycle rhythm [BP], DNA replication-dependent nucleosome assembly [BP], blastocyst hatching [BP], pancreatic polypeptide receptor activity [MF], CAF-1 complex [CC], DNA double-strand break processing involved in repair via single-strand annealing [BP]
CG_adsipsc_promoter_p_PM_12_243_16			1	0.2	3.51E-05	CYP4B1	fluorene metabolic process [BP], fluorene oxygenase activity [MF]
CG_adsipsc_promoter_p_PM_12_188_11			3	0.6	1.25E-04	PTH2R	parathyroid hormone receptor activity [MF]
CG_adsipsc_promoter_p_PM_20_27_63			1	0.2	6.90E-05	BAG4, DDR2	positive regulation of fibroblast migration [BP]
CG_adsipsc_promoter_p_PM_20_37_70			1	0.2	4.85E-05	BDKRB2, VPS26A, RAB4A, PRDX5, ARF6, CAT, SPPL2B, SLC26A7, ZNRF1, HBA2, HM13, PTPN23	endosome [CC], hydrogen peroxide catabolic process [BP], aspartic endopeptidase activity, intramembrane cleaving [MF], integral to cytosolic side of endoplasmic reticulum membrane [CC]
CG_adsipsc_promoter_p_PM_16_22_16			4	0.8	5.56E-05	FADD, PSMB3	necrotic cell death [BP], cellular nitrogen compound metabolic process [BP]
CG_adsipsc_promoter_p_PM_16_4_21			3	0.6	7.08E-05	HSPA14	'de novo' cotranslational protein folding [BP]
CG_adsipsc_promoter_p_PM_14_128_6			1	0.2	1.43E-04	IDUA	limb morphogenesis [BP], L-iduronidase activity [MF]
CG_adsipsc_promoter_p_PM_12_285_10			1	0.2	9.07E-05	TRPC1, VEGFA, ATP12A, XCL1	negative regulation of CD4-positive, alpha-beta T cell proliferation [BP], positive regulation of immunoglobulin production in mucosal tissue [BP], positive regulation of release of sequestered calcium ion into cytosol [BP], positive regulation of granzyme B production [BP], basophil chemotaxis [BP], positive regulation of T-helper 1 cell cytokine production [BP], positive regulation of CD8-positive, alpha-beta T cell proliferation [BP], hydrogen:potassium-exchanging ATPase complex [CC], positive regulation of granzyme A production [BP], positive regulation of CD4-positive, alpha-beta T cell proliferation [BP], negative regulation of T-helper 1 cell activation [BP], mature natural killer cell chemotaxis [BP]
CG_adsipsc_promoter_p_PM_12_202_4			1	0.2	6.40E-05	XRCC5, ZFPM1, IGHMBP2, SLC6A2, LHX9	ATP-dependent 5'-3' RNA helicase activity [MF], DNA helicase activity [MF], ATP-dependent DNA helicase activity [MF], norepinephrine:sodium symporter activity [MF], negative regulation of mast cell differentiation [BP], gonad morphogenesis [BP], negative regulation of interleukin-4 biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_16_60_22			3	0.6	8.39E-05	DNAAF1, SIRT1, PIK3C3, GATA1, EEF2K	p53 binding [MF], negative regulation of prostaglandin biosynthetic process [BP], response to insulin stimulus [BP], negative regulation of cellular response to testosterone stimulus [BP], establishment of chromatin silencing [BP], insulin receptor signaling pathway [BP], regulation of cilium beat frequency [BP], elongation factor-2 kinase activity [MF], negative regulation of cAMP-dependent protein kinase activity [BP]
CG_adsipsc_promoter_p_PM_14_19_28			3	0.6	1.22E-05	COMT	positive regulation of homocysteine metabolic process [BP], catechol O-methyltransferase activity [MF], negative regulation of dopamine metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_27_14			2	0.4	3.51E-05	MAPK15, CDK8, CDK1, STUB1	positive regulation of protein ubiquitination [BP], cyclin-dependent protein kinase activity [MF], Hsp70 protein binding [MF], RNA polymerase II carboxy-terminal domain kinase activity [MF], response to copper ion [BP]
CG_adsipsc_promoter_p_PM_12_155_14			3	0.6	1.27E-05	TGM4, LRWD1, IFNL1	negative regulation of memory T cell differentiation [BP], establishment of protein localization to chromatin [BP], interleukin-28 receptor binding [MF], protein polyamination [BP]
CG_adsipsc_promoter_p_PM_20_18_84			1	0.2	3.58E-05	ST3GAL6	beta-galactoside alpha-2,3-sialyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_1_16			2	0.4	8.22E-05	SIN3B, GLYCTK	Y chromosome [CC], autosome [CC], glycerate kinase activity [MF]
CG_adsipsc_promoter_p_PM_12_432_8			2	0.4	1.09E-04	ZFPM1, GCDH, CACNA1C	regulation of definitive erythrocyte differentiation [BP], primitive erythrocyte differentiation [BP], smooth muscle contraction involved in micturition [BP], transcriptional activation by promoter-enhancer looping [BP], glutaryl-CoA dehydrogenase activity [MF], negative regulation of mast cell differentiation [BP], mitral valve formation [BP], negative regulation of interleukin-4 biosynthetic process [BP], caveolar macromolecular signaling complex [CC], tricuspid valve formation [BP], calcium-mediated signaling using extracellular calcium source [BP]
CG_adsipsc_promoter_p_PM_14_123_11			3	0.6	4.89E-05	ATP2A2, ATP2A1	calcium-transporting ATPase activity [MF], platelet dense tubular network membrane [CC]
CG_adsipsc_promoter_p_PM_12_347_6			2	0.4	9.73E-05	WWP2	regulation of potassium ion transmembrane transporter activity [BP], negative regulation of transporter activity [BP]
CG_adsipsc_promoter_p_PM_20_26_101			2	0.2	5.93E-05	SETD8, SP1, EHMT1	megakaryocyte differentiation [BP], peptidyl-lysine monomethylation [BP]
CG_adsipsc_promoter_p_PM_12_190_9			1	0.2	1.01E-04	ATP11A, PI4K2A, BRCA2	BRCA2-MAGE-D1 complex [CC], early endosome [CC], host cell presynaptic membrane [CC], basophil degranulation [BP], AP-3 adaptor complex binding [MF]
CG_adsipsc_promoter_p_PM_16_45_32			1	0.2	3.07E-05	GZMA, ALDH3A2	medium-chain-aldehyde dehydrogenase activity [MF], negative regulation of endodeoxyribonuclease activity [BP], long-chain-aldehyde dehydrogenase activity [MF], long-chain-alcohol oxidase activity [MF]
CG_adsipsc_promoter_p_PM_14_124_4			2	0.4	1.21E-04	TDP1	3'-tyrosyl-DNA phosphodiesterase activity [MF]
CG_adsipsc_promoter_p_PM_12_206_8			3	0.6	4.88E-05	QPCT	peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [BP], glutaminyl-peptide cyclotransferase activity [MF]
CG_adsipsc_promoter_p_PM_14_126_5			1	0.2	5.03E-05	SART1	positive regulation of cytotoxic T cell differentiation [BP]
CG_adsipsc_promoter_p_PM_20_1_113			1	0.2	3.30E-05	EBI3	interleukin-27 receptor binding [MF]
CG_adsipsc_promoter_p_PM_14_86_18			2	0.4	4.40E-05	SNRPD1, SNRNP35	U12-type spliceosomal complex [CC]
CG_adsipsc_promoter_p_PM_12_182_19			2	0.4	5.06E-05	MSX1	apoptotic nuclear changes [BP]
CG_adsipsc_promoter_p_PM_14_36_8			1	0.2	3.48E-05	KCNV2, KCNQ4	delayed rectifier potassium channel activity [MF]
CG_adsipsc_promoter_p_PM_12_204_8			2	0.4	8.48E-05	CBR1	15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF], prostaglandin-E2 9-reductase activity [MF]
CG_adsipsc_promoter_p_PM_14_78_21			10	1.0	4.97E-05	PBX1, GATA6	transcription factor complex [CC]
CG_adsipsc_promoter_p_PM_12_502_13			5	0.8	6.63E-05	OPRL1, RIC8A	nociceptin receptor activity [MF], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_157_10			2	0.4	3.31E-04	MAPK8IP1, FAAH	fatty acid amide hydrolase activity [MF], dentate gyrus mossy fiber [CC]
CG_adsipsc_promoter_p_PM_14_122_9			1	0.2	4.01E-05	LPCAT2	1-alkylglycerophosphocholine O-acetyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_170_8			1	0.2	3.02E-05	MANEA, WNT9B	establishment of planar polarity involved in nephron morphogenesis [BP], mesonephric duct formation [BP], glycoprotein endo-alpha-1,2-mannosidase activity [MF]
CG_adsipsc_promoter_p_PM_14_11_27			12	1.0	5.46E-05	MLH1, MSH6, NUTF2	microtubule cytoskeleton [CC], somatic hypermutation of immunoglobulin genes [BP], negative regulation of DNA recombination [BP], mismatched DNA binding [MF], mismatch repair complex [CC], guanine/thymine mispair binding [MF]
CG_adsipsc_promoter_p_PM_12_471_9			1	0.2	1.55E-04	DLAT, PAPSS2	sulfate adenylyltransferase (ATP) activity [MF], dihydrolipoyllysine-residue acetyltransferase activity [MF], mitochondrial pyruvate dehydrogenase complex [CC], adenylylsulfate kinase activity [MF], 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_425_13			2	0.4	2.23E-04	GMPPA, MAG, APOE	mannose-1-phosphate guanylyltransferase activity [MF], positive regulation of low-density lipoprotein particle receptor catabolic process [BP], metal chelating activity [MF], regulation of axonogenesis [BP]
CG_adsipsc_promoter_p_PM_12_381_12			2	0.2	2.26E-04	IL25	interleukin-17E receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_263_13			3	0.4	1.99E-04	CSGALNACT2, KCNAB2, RIPK1	protein heterooligomerization [BP], dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [BP], regulation of ATP:ADP antiporter activity [BP]
CG_adsipsc_promoter_p_PM_12_227_13			1	0.2	2.51E-04	NOS3, PHAX, MVK	negative regulation of muscle hyperplasia [BP], isopentenyl diphosphate biosynthetic process, mevalonate pathway [BP], smooth muscle hyperplasia [BP], mevalonate kinase activity [MF], snRNA export from nucleus [BP]
CG_adsipsc_promoter_p_PM_16_10_28			5	1.0	2.44E-05	LIMK1, NDEL1, ISL1	axon regeneration [BP], positive regulation of axon extension [BP]
CG_adsipsc_promoter_p_PM_14_64_24			5	1.0	3.97E-05	CCL20	chemokinesis [BP]
CG_adsipsc_promoter_p_PM_12_377_12			3	0.6	4.39E-05	MAPRE1	cortical microtubule cytoskeleton [CC]
CG_adsipsc_promoter_p_PM_18_5_65			4	0.8	3.54E-05	FBXO18, DRD5, ZRANB1, ZNF213, KLF2, LAP3, EIF2B5, AIP, TCF7L1, ZFP90, IQGAP1, ZNF74, TPX2, NUSAP1, ATXN1L, HIC1, GRHL3, RAD54L, ZNF575, RBM10, HIST1H2AC, ZNF345, ZNF646, SMAD6, HSD17B6, WSB1, BEX4, AQP2, RAC1, PKN1, LIN28B, ASCL4, PLCD4, CHP2, ZNF805, NAT14, SPECC1, DNAJA3, NFIX, APOBEC3H, FTSJD2, DRD4, SRRM2, CALML6, ZKSCAN1, NGRN, PRDM2, SUPT5H, TRIP6, ZNF775, ARID1A, EP300	intracellular [CC], negative regulation of dephosphorylation [BP], regulation of calcium-mediated signaling [BP], dopamine neurotransmitter receptor activity [MF], hyperosmotic response [BP], nucleus [CC]
CG_adsipsc_promoter_p_PM_12_475_8			2	0.4	3.67E-04	AKR1D1, INHA	bile acid catabolic process [BP], inhibin-betaglycan-ActRII complex [CC], inhibin A complex [CC], delta4-3-oxosteroid 5beta-reductase activity [MF], positive regulation of follicle-stimulating hormone secretion [BP]
CG_adsipsc_promoter_p_PM_12_316_11			3	0.6	2.99E-05	SPHK1, ITCH, BIRC3, APOBEC3B, L3MBTL1, MLYCD	negative regulation of necroptosis [BP], nucleotide-binding oligomerization domain containing signaling pathway [BP], malonyl-CoA catabolic process [BP], malonyl-CoA decarboxylase activity [MF], nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP], sphingoid catabolic process [BP], SAM domain binding [MF], defense response to virus [BP]
CG_adsipsc_promoter_p_PM_12_106_14			3	0.6	4.67E-05	GRK6, GRK1, SNX17	intracellular protein transport [BP], G-protein coupled receptor kinase activity [MF]
CG_adsipsc_promoter_p_PM_20_21_68			1	0.2	4.79E-05	CCNB1, SLC25A33, PMPCA, CDC73, WDR93, PSEN2, MACF1, VAMP3, SLC25A37, GNA15, MDH2, TNRC6A, GNA11, DUSP21, AGO1, MARC2, RTF1, ATCAY	micro-ribonucleoprotein complex [CC], mitochondrial membrane [CC], phospholipase C-activating dopamine receptor signaling pathway [BP], mitochondrial inner membrane [CC], Golgi to plasma membrane protein transport [BP], negative regulation of translation involved in gene silencing by miRNA [BP], Cdc73/Paf1 complex [CC], positive regulation of mRNA 3'-end processing [BP]
CG_adsipsc_promoter_p_PM_12_228_9			3	0.6	2.76E-04	MAN2A2, SLC25A5, CYP46A1	mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [MF], adenine transmembrane transporter activity [MF], negative regulation of mitochondrial outer membrane permeabilization [BP], adenine transport [BP], cholesterol 24-hydroxylase activity [MF]
CG_adsipsc_promoter_p_PM_16_61_23			4	0.8	4.67E-05	ZNF143, POLR3F	regulation of transcription from RNA polymerase III promoter [BP]
CG_adsipsc_promoter_p_PM_12_47_12			3	0.4	1.95E-04	CRTAM, PTX3, OR2H2	(1->3)-beta-D-glucan binding [MF], detection of tumor cell [BP], defense response [BP]
CG_adsipsc_promoter_p_PM_16_39_18			2	0.4	7.82E-05	VEZT, GPI, ATCAY, RAB10	negative regulation of glutamate metabolic process [BP], myosin binding [MF], glucose-6-phosphate isomerase activity [MF], methylglyoxal biosynthetic process [BP], establishment of protein localization to endoplasmic reticulum membrane [BP]
CG_adsipsc_promoter_p_PM_12_414_8			2	0.4	2.96E-05	TICRR, CFLAR	negative regulation of myoblast fusion [BP], G2/M transition checkpoint [BP]
CG_adsipsc_promoter_p_PM_12_232_11			2	0.4	3.60E-05	CACNG6, CACNG8	voltage-gated calcium channel activity [MF], voltage-gated calcium channel complex [CC]
CG_adsipsc_promoter_p_PM_12_433_9			2	0.4	4.32E-05	ALG1, SLC5A1	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], glucose:sodium symporter activity [MF]
CG_adsipsc_promoter_p_PM_14_32_8			1	0.2	7.63E-05	STEAP3	ferric-chelate reductase activity [MF]
CG_adsipsc_promoter_p_PM_12_487_13			3	0.6	1.10E-05	RPS15, NOC4L	ribosomal small subunit export from nucleus [BP], rRNA processing [BP]
CG_adsipsc_promoter_p_PM_12_198_9			2	0.4	3.29E-05	ACTR3	regulation of myosin II filament organization [BP]
CG_adsipsc_promoter_p_PM_12_418_6			1	0.2	2.72E-04	GLP2R, GCAT	glycine C-acetyltransferase activity [MF], L-threonine catabolic process to glycine [BP], glucagon receptor activity [MF]
CG_adsipsc_promoter_p_PM_16_51_36			4	0.8	6.63E-05	PTPN11	regulation of cell adhesion mediated by integrin [BP]
CG_adsipsc_promoter_p_PM_14_31_10			3	0.6	3.42E-05	FZR1, CDKN1B, APC	negative regulation of cyclin-dependent protein kinase activity [BP], negative regulation of epithelial cell proliferation involved in prostate gland development [BP], positive regulation of protein catabolic process [BP], positive regulation of microtubule polymerization [BP]
CG_adsipsc_promoter_p_PM_20_17_104			1	0.2	5.25E-05	BUB1B, VAPA, PGAM1, RBBP4, P2RX7, NCOA3, LHX1, PIK3CD, PIK3R2, KLHL10, SLC44A2, MTMR14, CNP, CENPH, CEP63, CENPA, LDLR, BAX, CASC5, INPP1, BBS4, FBXL7, CDC20, SPHK1	phospholipid metabolic process [BP], microtubule cytoskeleton organization [BP], lipid metabolic process [BP], mitosis [BP], mitotic prometaphase [BP], vagina development [BP], cellular lipid metabolic process [BP], respiratory burst [BP], protein localization to chromosome, centromeric region [BP], spermatid differentiation [BP], phosphate-containing compound metabolic process [BP], CENP-A containing nucleosome assembly at centromere [BP], homeostasis of number of cells within a tissue [BP]
CG_adsipsc_promoter_p_PM_14_100_9			1	0.2	6.64E-05	ABCG8	negative regulation of intestinal phytosterol absorption [BP], negative regulation of intestinal cholesterol absorption [BP]
CG_adsipsc_promoter_p_PM_14_112_28			2	0.4	1.23E-05	CYC1	electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity [MF]
CG_adsipsc_promoter_p_PM_12_86_9			2	0.4	5.18E-05	COL3A1, KMO	collagen type III [CC], kynurenine 3-monooxygenase activity [MF]
CG_adsipsc_promoter_p_PM_12_115_12			3	0.6	1.48E-04	MYOCD	regulation of myoblast differentiation [BP]
CG_adsipsc_promoter_p_PM_12_118_8			1	0.2	1.20E-04	IL4, TGIF1, SLC22A3, BMPR1A	negative regulation of T-helper 17 cell differentiation [BP], connective tissue growth factor biosynthetic process [BP], histamine uptake [BP], neural plate mediolateral regionalization [BP], paraxial mesoderm structural organization [BP], regulation of gastrulation [BP]
CG_adsipsc_promoter_p_PM_12_193_12			2	0.4	1.84E-04	CYR61	intussusceptive angiogenesis [BP]
CG_adsipsc_promoter_p_PM_12_397_14			2	0.4	1.72E-04	WDR55, NOC4L	rRNA processing [BP]
CG_adsipsc_promoter_p_PM_12_84_5			2	0.4	1.14E-04	PSMD14	proteasome regulatory particle, lid subcomplex [CC]
CG_adsipsc_promoter_p_PM_12_507_16			4	0.8	4.81E-05	CLIP2, DNAH10, BICD1, APC2	microtubule [CC], cytoplasmic microtubule [CC]
CG_adsipsc_promoter_p_PM_18_6_47			4	0.8	5.21E-05	KHDC3L, KIF3B, KPNA2, DAG1, NAA16	N-terminal protein amino acid acetylation [BP], spindle assembly involved in mitosis [BP], NLS-bearing substrate import into nucleus [BP]
CG_adsipsc_promoter_p_PM_18_10_44			3	0.6	7.51E-05	RBM6, AGBL5, HINFP, HABP4, UPF1, APOC1, PIN1, SWAP70, ZNF451, NANOG, ZNF146, COMMD1, CDK5R1, COPG1, GTF2I, FEM1B, RPS27, FBXO40, ANKRD42, HOOK3, PRKCG, POLR2B, PLEKHO1, FSD1, ZNF613, PRCC, CASP8, CDC20, HKR1, UBC, BUD31, SOAT2	very-low-density lipoprotein particle assembly [BP], Golgi localization [BP], regulation of ubiquitin-protein ligase activity [BP], cell cycle checkpoint [BP], nucleus [CC]
CG_adsipsc_promoter_p_PM_12_138_5			2	0.4	1.56E-05	PPCDC, GLI2	spinal cord ventral commissure morphogenesis [BP], smoothened signaling pathway involved in ventral spinal cord interneuron specification [BP], notochord regression [BP], smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [BP], smoothened signaling pathway involved in dorsal/ventral neural tube patterning [BP], floor plate formation [BP], phosphopantothenoylcysteine decarboxylase activity [MF]
CG_adsipsc_promoter_p_PM_12_496_21			2	0.4	7.46E-05	PPCS	phosphopantothenate--cysteine ligase activity [MF]
CG_adsipsc_promoter_p_PM_14_89_6			2	0.4	5.95E-04	ZNF224, ZNF225, ZNF620, ZNF793, ZNF233, ZNF587, ZNF586, COPS6, ZNF222	transcription, DNA-dependent [BP], DNA binding [MF], zinc ion binding [MF], regulation of transcription, DNA-dependent [BP], nucleus [CC]
CG_adsipsc_promoter_p_PM_12_394_9			2	0.4	1.06E-04	AHCYL1	adenosylhomocysteinase activity [MF]
CG_adsipsc_promoter_p_PM_18_40_110			4	0.8	7.49E-05	HERPUD1, USPL1, UBE2A, UNC79, PSMD9, UBE2D2, CAP1, USP43, CUL4A, USP9X, CRHBP, SLC27A4, CD3G, SLC27A1, CTNNA1, USP20, DBH	establishment or maintenance of cell polarity [BP], ubiquitin-dependent protein catabolic process [BP], medium-chain fatty acid transport [BP], behavioral response to ethanol [BP]
CG_adsipsc_promoter_p_PM_14_39_14			4	0.8	8.36E-05	XYLT2	protein xylosyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_126_10			3	0.6	2.25E-04	VRTN, TPSAB1, SERPINE1	negative regulation of smooth muscle cell-matrix adhesion [BP], negative regulation of vascular wound healing [BP], negative regulation of plasminogen activation [BP], extracellular matrix [CC], positive regulation of leukotriene production involved in inflammatory response [BP], chronological cell aging [BP], transposase activity [MF], transposition, DNA-mediated [BP]
CG_adsipsc_promoter_p_PM_12_332_8			1	0.2	2.43E-04	DIO3, IL1RN	interleukin-1 Type II receptor antagonist activity [MF], thyroxine 5-deiodinase activity [MF], interleukin-1 Type I receptor antagonist activity [MF]
CG_adsipsc_promoter_p_PM_12_328_17			2	0.4	1.24E-04	FMN2	meiotic chromosome movement towards spindle pole [BP]
CG_adsipsc_promoter_p_PM_12_338_5			2	0.4	1.62E-04	CYR61, PROM2, PDZK1, NLGN2	prominosome [CC], intussusceptive angiogenesis [BP], scavenger receptor binding [MF], positive regulation of inhibitory postsynaptic membrane potential [BP]
CG_adsipsc_promoter_p_PM_12_91_11			3	0.6	4.49E-04	RHOQ	GBD domain binding [MF]
CG_adsipsc_promoter_p_PM_16_35_36			3	0.6	2.46E-05	BRCC3, UHRF2, USP20, HDAC1	negative regulation of cell cycle [BP], protein K63-linked deubiquitination [BP], positive regulation of cell cycle arrest [BP]
CG_adsipsc_promoter_p_PM_12_411_9			2	0.4	2.18E-05	FEM1A, VEGFA, ADRA2C, NBL1	basophil chemotaxis [BP], positive regulation of neuron differentiation [BP], EP4 subtype prostaglandin E2 receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_153_11			3	0.6	3.89E-05	UBE2B, OTUB1, GPX4, CLIC6	D4 dopamine receptor binding [MF], D2 dopamine receptor binding [MF], positive regulation of reciprocal meiotic recombination [BP], negative regulation of histone phosphorylation [BP], NEDD8-specific protease activity [MF], histone H2A ubiquitination [BP], phospholipid-hydroperoxide glutathione peroxidase activity [MF], protein K63-linked ubiquitination [BP], D3 dopamine receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_415_9			2	0.4	1.36E-04	STRA8, TFAP2C	female meiosis sister chromatid cohesion [BP], meiotic cell cycle DNA replication checkpoint [BP], dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], meiotic DNA double-strand break formation [BP]
CG_adsipsc_promoter_p_PM_14_102_11			2	0.4	4.94E-05	ASPG, LDLR	very-low-density lipoprotein particle receptor activity [MF], asparaginase activity [MF]
CG_adsipsc_promoter_p_PM_12_390_12			2	0.4	7.91E-05	MICB, MICA, PSAT1	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [MF], natural killer cell lectin-like receptor binding [MF], MHC class I protein complex [CC], gamma-delta T cell activation [BP], response to heat [BP], cytolysis [BP]
CG_adsipsc_promoter_p_PM_18_30_46			3	0.6	1.35E-04	ZP3, TSEN34	positive regulation of type IV hypersensitivity [BP], tRNA-intron endonuclease activity [MF], positive regulation of antral ovarian follicle growth [BP], outer acrosomal membrane [CC], positive regulation of phosphatidylinositol biosynthetic process [BP], positive regulation of acrosomal vesicle exocytosis [BP], tRNA-type intron splice site recognition and cleavage [BP], positive regulation of ovarian follicle development [BP], manganese ion transmembrane transport [BP]
CG_adsipsc_promoter_p_PM_12_103_18			2	0.4	1.12E-04	MYRF, ZFPM1, RNF10, MVK	mevalonate kinase activity [MF], negative regulation of interleukin-4 biosynthetic process [BP], positive regulation of myelination [BP], negative regulation of mast cell differentiation [BP]
CG_adsipsc_promoter_p_PM_12_497_20			3	0.6	9.33E-05	STXBP3	neutrophil degranulation [BP]
CG_adsipsc_promoter_p_PM_12_199_10			3	0.6	1.17E-04	SQSTM1, GSDMD, DNAJA3, ARHGAP5	SH2 domain binding [MF], cellular response to extracellular stimulus [BP], receptor tyrosine kinase binding [MF]
CG_adsipsc_promoter_p_PM_12_117_15			2	0.4	7.33E-05	RXFP1	lung connective tissue development [BP]
CG_adsipsc_promoter_p_PM_14_7_17			1	0.2	1.15E-05	AGPHD1	hydroxylysine kinase activity [MF]
CG_adsipsc_promoter_p_PM_12_314_6			2	0.4	1.04E-04	WDYHV1, ACSF3	malonate catabolic process [BP], protein-N-terminal glutamine amidohydrolase activity [MF], malonyl-CoA synthetase activity [MF]
CG_adsipsc_promoter_p_PM_12_82_11			2	0.4	9.89E-05	HPRT1, TBX2	atrioventricular canal development [BP], positive regulation of dopamine metabolic process [BP], negative regulation of cardiac chamber formation [BP], GMP salvage [BP], guanine salvage [BP], adenine salvage [BP], pharynx development [BP], negative regulation of heart looping [BP], muscle cell fate determination [BP], hypoxanthine phosphoribosyltransferase activity [MF], guanine phosphoribosyltransferase activity [MF], GMP catabolic process [BP]
CG_adsipsc_promoter_p_PM_14_82_9			1	0.2	3.25E-05	BRCA2, P2RX7, ING2, HSP90AB1	BRCA2-MAGE-D1 complex [CC], male meiosis I [BP], nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_14_125_11			2	0.4	3.64E-05	PAPD7	SMC family protein binding [MF]
CG_adsipsc_promoter_p_PM_12_296_9			2	0.4	2.75E-05	CDKN1A	positive regulation of reactive oxygen species metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_62_15			2	0.4	4.83E-05	BSG, TET3, FBLN1	embryo implantation [BP], DNA demethylation of male pronucleus [BP]
CG_adsipsc_promoter_p_PM_12_97_13			2	0.4	4.51E-05	AMY2B	alpha-amylase activity [MF]
CG_adsipsc_promoter_p_PM_12_113_9			2	0.4	2.12E-04	THNSL1	threonine biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_14_80_8			3	0.6	2.06E-05	DUT, SAE1	SUMO activating enzyme activity [MF], dUTP metabolic process [BP], dUTP diphosphatase activity [MF], dUMP biosynthetic process [BP], ubiquitin activating enzyme activity [MF]
CG_adsipsc_promoter_p_PM_18_29_40			3	0.6	7.34E-05	SIRT1, GATA1, DNAAF1	p53 binding [MF], negative regulation of prostaglandin biosynthetic process [BP], transcriptional activation by promoter-enhancer looping [BP], motile cilium assembly [BP], cellular response to starvation [BP], inner dynein arm assembly [BP], establishment of chromatin silencing [BP], negative regulation of cellular response to testosterone stimulus [BP], basophil differentiation [BP], regulation of cilium beat frequency [BP], eosinophil fate commitment [BP], negative regulation of cAMP-dependent protein kinase activity [BP], outer dynein arm assembly [BP], positive regulation of cAMP-dependent protein kinase activity [BP]
CG_adsipsc_promoter_p_PM_12_3_6			2	0.4	3.44E-05	GLUD2, H1FOO	female germ cell nucleus [CC], glutamate dehydrogenase [NAD(P)+] activity [MF], glutamate dehydrogenase (NAD+) activity [MF]
CG_adsipsc_promoter_p_PM_12_335_7			2	0.4	2.98E-04	NIT1	nitrilase activity [MF]
CG_adsipsc_promoter_p_PM_12_452_8			2	0.4	2.11E-04	PCBD2	4-alpha-hydroxytetrahydrobiopterin dehydratase activity [MF], phenylalanine 4-monooxygenase activity [MF]
CG_adsipsc_promoter_p_PM_12_369_14			2	0.4	9.78E-05	FTL, MIOX	ferric iron binding [MF]
CG_adsipsc_promoter_p_PM_14_20_15			1	0.2	2.39E-04	SUN1	nuclear matrix anchoring at nuclear membrane [BP]
CG_adsipsc_promoter_p_PM_12_331_8			2	0.4	2.58E-05	CARNS1, MAP3K4, MAVS	carnosine synthase activity [MF], positive regulation of chemokine (C-C motif) ligand 5 production [BP], male germ-line sex determination [BP], positive regulation of IP-10 production [BP], carnosine biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_492_12			1	0.2	4.05E-05	RAD51	positive regulation of DNA ligation [BP]
CG_adsipsc_promoter_p_PM_12_370_7			2	0.4	1.14E-04	PNRC2, TCTN1	deadenylation-independent decapping of nuclear-transcribed mRNA [BP], central nervous system interneuron axonogenesis [BP]
CG_adsipsc_promoter_p_PM_14_129_23			3	0.4	5.53E-05	HMGA2, RBM4	histone H2A-S139 phosphorylation [BP], MH2 domain binding [MF], circadian regulation of translation [BP], chromosome breakage [BP], IRES-dependent translational initiation [BP], cap-independent translational initiation [BP], positive regulation of cellular response to X-ray [BP], pre-mRNA intronic pyrimidine-rich binding [MF], MH1 domain binding [MF], negative regulation of double-strand break repair via nonhomologous end joining [BP], mesodermal-endodermal cell signaling [BP]
CG_adsipsc_promoter_p_PM_12_66_10			3	0.6	1.25E-04	ATCAY	negative regulation of glutamate metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_409_13			1	0.2	7.67E-05	HSD17B7	3-keto sterol reductase activity [MF]
CG_adsipsc_promoter_p_PM_12_363_17			3	0.6	2.40E-04	NF1, KNG1	negative regulation of cell adhesion [BP], negative regulation of MAP kinase activity [BP], negative regulation of MAPK cascade [BP]
CG_adsipsc_promoter_p_PM_12_259_8			2	0.4	2.27E-04	CEP192, NEK6	spindle assembly [BP]
CG_adsipsc_promoter_p_PM_14_26_16			3	0.4	1.30E-05	AGRN, ENOPH1, SLC7A2, SMO	mesenchymal to epithelial transition involved in metanephric renal vesicle formation [BP], otolith morphogenesis [BP], ventral midline determination [BP], detection of cell density by contact stimulus involved in contact inhibition [BP], acireductone synthase activity [MF], receptor clustering [BP], positive regulation of synaptic growth at neuromuscular junction [BP], high affinity arginine transmembrane transporter activity [MF]
CG_adsipsc_promoter_p_PM_12_462_10			2	0.4	1.01E-04	MLH1, ADCY2, CETN1	spindle midzone assembly involved in meiosis [BP], G-protein beta/gamma-subunit complex binding [MF], meiotic metaphase I plate congression [BP]
CG_adsipsc_promoter_p_PM_20_33_138			1	0.2	4.99E-05	RAC1, IREB2, UROD	protoporphyrinogen IX biosynthetic process [BP], regulation of respiratory burst [BP]
CG_adsipsc_promoter_p_PM_12_494_14			3	0.6	1.96E-04	PHAX	snRNA export from nucleus [BP]
CG_adsipsc_promoter_p_PM_20_2_70			1	0.2	3.35E-05	UBE2I, MYB, JARID2, RANBP2, TRPM4	positive regulation of histone H3-K9 methylation [BP], protein sumoylation [BP]
CG_adsipsc_promoter_p_PM_14_18_13			4	0.8	1.52E-04	BCMO1	beta-carotene 15,15'-monooxygenase activity [MF], vitamin A biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_383_14			2	0.4	8.70E-05	MPST	3-mercaptopyruvate sulfurtransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_434_9			2	0.4	4.84E-05	CCNB1	regulation of chromosome condensation [BP], response to DDT [BP], cellular response to iron(III) ion [BP], positive regulation of attachment of spindle microtubules to kinetochore [BP]
CG_adsipsc_promoter_p_PM_12_174_12			2	0.4	1.90E-04	IL6R	ciliary neurotrophic factor binding [MF]
CG_adsipsc_promoter_p_PM_14_117_14			1	0.2	6.61E-05	COG6, CANX, MPI, ST3GAL4	glycosylation [BP], protein N-linked glycosylation via asparagine [BP]
CG_adsipsc_promoter_p_PM_18_27_19			2	0.4	2.89E-05	POLR2B, POLR2G	transcription elongation from RNA polymerase II promoter [BP], DNA-directed RNA polymerase II, core complex [CC]
CG_adsipsc_promoter_p_PM_12_38_9			1	0.2	1.77E-04	PLOD1, DBH	hydroxylysine biosynthetic process [BP], L-ascorbic acid binding [MF], chromaffin granule lumen [CC], homoiothermy [BP]
CG_adsipsc_promoter_p_PM_12_468_11			2	0.4	1.37E-04	GSTM4	xenobiotic catabolic process [BP]
CG_adsipsc_promoter_p_PM_16_36_22			4	0.8	5.58E-05	OXA1L, PXK	negative regulation of ATPase activity [BP]
CG_adsipsc_promoter_p_PM_20_9_114			1	0.2	5.11E-05	DOCK8, ATP2A1, CSK, PTPN11, CD40, RGS9, MAPK14, ADIPOQ, GATA6, DOCK11, DGKD, TENC1	blood coagulation [BP], intracellular signal transduction [BP], negative regulation of intracellular protein transport [BP], positive regulation of Cdc42 GTPase activity [BP], negative regulation of phagocytosis [BP]
CG_adsipsc_promoter_p_PM_12_93_27			3	0.6	8.36E-05	PLK1, CCNE1, CD2AP, CCNF, RABEP1, RALA, DIAPH2	cytokinesis [BP], cell division [BP]
CG_adsipsc_promoter_p_PM_12_37_14			2	0.4	2.41E-04	CSTF1, MIF, NUP214, ARFGEF2, NR1H4, PPP2R2A	symmetric synapse [CC], mRNA metabolic process [BP], gene expression [BP], RNA metabolic process [BP], phenylpyruvate tautomerase activity [MF]
CG_adsipsc_promoter_p_PM_12_465_9			1	0.2	7.13E-05	CPS1, XYLT2	carbamoyl-phosphate synthase (ammonia) activity [MF], protein xylosyltransferase activity [MF], carbamoyl phosphate biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_22_12			4	0.6	1.39E-04	UBE4B, GRK4, RGS18, NRG1	termination of G-protein coupled receptor signaling pathway [BP], ventricular trabecula myocardium morphogenesis [BP]
CG_adsipsc_promoter_p_PM_12_256_9			2	0.4	3.95E-05	ENPP1	inorganic diphosphate transport [BP], NADH pyrophosphatase activity [MF]
CG_adsipsc_promoter_p_PM_16_8_31			2	0.2	3.12E-05	DRD5, DRD4	dopamine binding [MF], dopamine neurotransmitter receptor activity [MF]
CG_adsipsc_promoter_p_PM_14_22_11			1	0.2	1.40E-05	FUK, PHACTR4	protein phosphatase type 1 activator activity [MF], fucokinase activity [MF], negative regulation of integrin-mediated signaling pathway [BP]
CG_adsipsc_promoter_p_PM_14_67_9			1	0.2	1.64E-05	DFFB, ME2, CYP4F3	apoptotic chromosome condensation [BP], alpha-tocopherol omega-hydroxylase activity [MF], malate dehydrogenase (decarboxylating) activity [MF], electron carrier activity [MF]
CG_adsipsc_promoter_p_PM_12_147_7			3	0.6	1.09E-04	HIF1A	neural fold elevation formation [BP]
CG_adsipsc_promoter_p_PM_12_205_10			2	0.4	6.20E-05	ADK, F11	serine-type aminopeptidase activity [MF], AMP salvage [BP], dATP biosynthetic process [BP], adenosine kinase activity [MF]
CG_adsipsc_promoter_p_PM_12_398_9			2	0.4	2.59E-04	PPP2R4, MSRA, AQP1	nitric oxide transport [BP], establishment or maintenance of actin cytoskeleton polarity [BP], carbon dioxide transmembrane transporter activity [MF], symbiont-containing vacuole membrane [CC], cellular response to salt stress [BP], maintenance of symbiont-containing vacuole by host [BP], negative regulation of protein dephosphorylation [BP], cerebrospinal fluid secretion [BP], intracellular cGMP activated cation channel activity [MF], transepithelial water transport [BP], response to oxidative stress [BP], peptide-methionine (S)-S-oxide reductase activity [MF], glycerol transport [BP], protein tyrosine phosphatase activator activity [MF], carbon dioxide transmembrane transport [BP], symbiont-containing vacuole [CC], cellular response to mercury ion [BP], nitric oxide transmembrane transporter activity [MF]
CG_adsipsc_promoter_p_PM_12_364_14			3	0.6	4.55E-04	ADM2	feeding behavior [BP]
CG_adsipsc_promoter_p_PM_12_385_15			3	0.6	3.11E-05	SERPINA5, EMG1, CARTPT	protein C inhibitor-PLAT complex [CC], protein C inhibitor-thrombin complex [CC], protein C inhibitor-coagulation factor V complex [CC], rRNA (pseudouridine) methyltransferase activity [MF], protein C inhibitor-TMPRSS7 complex [CC], protein C inhibitor-coagulation factor Xa complex [CC], protein C inhibitor-KLK3 complex [CC], protein C inhibitor-TMPRSS11E complex [CC], positive regulation of epinephrine secretion [BP], protein C inhibitor-coagulation factor XI complex [CC], protein C inhibitor-PLAU complex [CC], protein C inhibitor-plasma kallikrein complex [CC]
CG_adsipsc_promoter_p_PM_12_12_8			1	0.2	1.36E-04	TRNT1, CRTAP, CPSF3	tRNA 3'-terminal CCA addition [BP], ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [MF], CTP:tRNA cytidylyltransferase activity [MF], tRNA nucleotidyltransferase activity [MF], peptidyl-proline hydroxylation to 3-hydroxy-L-proline [BP], tRNA adenylyltransferase activity [MF], CTP:3'-cytidine-tRNA cytidylyltransferase activity [MF], endoribonuclease activity [MF]
CG_adsipsc_promoter_p_PM_20_4_200			1	0.2	5.39E-05	ARHGAP35, PTK7, TGIF1, BBS4, PHACTR4	neural tube closure [BP]
CG_adsipsc_promoter_p_PM_12_278_18			2	0.4	1.57E-05	ACADS, HTR6	negative regulation of gamma-aminobutyric acid secretion [BP], butyrate catabolic process [BP], negative regulation of acetylcholine secretion [BP], butyryl-CoA dehydrogenase activity [MF]
CG_adsipsc_promoter_p_PM_14_65_5			1	0.2	1.11E-04	NUDT9, AGRN	IDP catabolic process [BP], ADP catabolic process [BP], positive regulation of synaptic growth at neuromuscular junction [BP]
CG_adsipsc_promoter_p_PM_20_15_78			1	0.2	5.52E-05	DPCD, HDAC11, DNAAF1, SMARCA4, GATA1, SIRT1	protein deacetylase activity [MF], NAD-dependent protein deacetylase activity [MF], left/right pattern formation [BP], NAD-dependent histone deacetylase activity [MF], p53 binding [MF], histone deacetylase activity [MF], negative regulation of androgen receptor signaling pathway [BP], NAD-dependent histone deacetylase activity (H3-K9 specific) [MF]
CG_adsipsc_promoter_p_PM_14_16_11			2	0.4	2.53E-05	SLC11A1, ITIH3	divalent metal ion export [BP], metal ion:hydrogen antiporter activity [MF], L-arginine import [BP], negative regulation of endopeptidase activity [BP], cellular cadmium ion homeostasis [BP], interleukin-3 production [BP], nitrite transport [BP], tertiary granule membrane [CC]
CG_adsipsc_promoter_p_PM_14_74_10			3	0.6	2.73E-05	GCDH, COMT	positive regulation of homocysteine metabolic process [BP], glutaryl-CoA dehydrogenase activity [MF]
CG_adsipsc_promoter_p_PM_20_22_73			1	0.2	4.51E-05	AK4, TNFRSF8, AZU1, COMMD1	ATP metabolic process [BP], positive regulation of tumor necrosis factor biosynthetic process [BP], copper ion homeostasis [BP]
CG_adsipsc_promoter_p_PM_12_312_10			3	0.6	1.08E-04	PPIA, CDH13	adiponectin binding [MF], uncoating of virus [BP]
CG_adsipsc_promoter_p_PM_12_378_8			2	0.4	1.57E-04	LANCL2	positive regulation of abscisic acid mediated signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_172_13			2	0.4	8.08E-05	MAPRE3, TUBA1C	cytoplasmic microtubule [CC]
CG_adsipsc_promoter_p_PM_12_258_4			1	0.2	1.77E-04	QPRT	quinolinate catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_250_7			3	0.6	8.52E-05	TPGS1, CTF1, MLH1, TCTN2	microtubule basal body [CC], spindle midzone assembly involved in meiosis [BP], negative regulation of mitotic recombination [BP], meiotic metaphase I plate congression [BP], leukemia inhibitory factor receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_81_8			1	0.2	1.55E-04	KLHL41	regulation of lateral pseudopodium assembly [BP]
CG_adsipsc_promoter_p_PM_12_354_7			2	0.4	5.92E-05	ACO1	citrate hydro-lyase (cis-aconitate-forming) activity [MF], aconitate hydratase activity [MF], isocitrate hydro-lyase (cis-aconitate-forming) activity [MF], response to iron(II) ion [BP]
CG_adsipsc_promoter_p_PM_14_28_12			2	0.4	9.46E-05	HPRT1	guanine salvage [BP], hypoxanthine phosphoribosyltransferase activity [MF], GMP catabolic process [BP], guanine phosphoribosyltransferase activity [MF], GMP salvage [BP]
CG_adsipsc_promoter_p_PM_12_482_4			2	0.4	1.91E-04	SMARCB1	blastocyst hatching [BP]
CG_adsipsc_promoter_p_PM_16_40_34			5	1.0	7.97E-05	KAT7, PHF17	histone H4-K12 acetylation [BP]
CG_adsipsc_promoter_p_PM_12_57_11			2	0.4	2.22E-04	PDE8B, SRD5A1	cholestenone 5-alpha-reductase activity [MF], 3-oxo-5-alpha-steroid 4-dehydrogenase activity [MF], phosphorelay response regulator activity [MF]
CG_adsipsc_promoter_p_PM_12_85_5			2	0.4	2.57E-05	MTO1, TP63	ectoderm and mesoderm interaction [BP], mitochondrial tRNA wobble uridine modification [BP]
CG_adsipsc_promoter_p_PM_12_318_20			3	0.6	1.74E-04	TUBB1, MX2, RAB31, BUB1B, TUBG1	spindle organization [BP], GTPase activity [MF]
CG_adsipsc_promoter_p_PM_14_10_11			12	1.0	7.37E-05	CCR2, ARRB2, TFAP2C, BIRC7	T-helper 17 cell chemotaxis [BP], dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], negative regulation of eosinophil degranulation [BP], positive regulation of CD8-positive, alpha-beta T cell extravasation [BP], positive regulation of monocyte extravasation [BP], alpha-1A adrenergic receptor binding [MF], type 2A serotonin receptor binding [MF], positive regulation of astrocyte chemotaxis [BP], follicle-stimulating hormone receptor binding [MF], regulation of natural killer cell apoptotic process [BP]
CG_adsipsc_promoter_p_PM_14_24_11			3	0.6	9.22E-05	PLA2G5, ARSH, LPIN3, AGPAT3	phosphatidic acid biosynthetic process [BP], phospholipid metabolic process [BP], glycerophospholipid biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_251_10			2	0.4	2.95E-05	CYP46A1, CBR3, ARHGEF10	phylloquinone catabolic process [BP], positive regulation of GTP catabolic process [BP], cholesterol 24-hydroxylase activity [MF]
CG_adsipsc_promoter_p_PM_12_395_14			5	0.8	2.88E-05	PRLH, CASC5, CX3CL1	acrosomal vesicle [CC], reduction of food intake in response to dietary excess [BP], positive regulation of calcium-independent cell-cell adhesion [BP], prolactin-releasing peptide receptor binding [MF], leukocyte adhesive activation [BP]
CG_adsipsc_promoter_p_PM_14_59_36			4	0.8	6.78E-05	NPM1, ASS1	argininosuccinate synthase activity [MF], regulation of endoribonuclease activity [BP]
CG_adsipsc_promoter_p_PM_14_83_11			2	0.4	3.22E-05	LLGL1, GDF11	maintenance of apical/basal cell polarity [BP], spinal cord anterior/posterior patterning [BP]
CG_adsipsc_promoter_p_PM_12_503_8			2	0.4	8.68E-05	ALLC	allantoicase activity [MF], allantoin catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_231_9			2	0.4	9.68E-05	EMD, TET1, DNAJC5, HTT, YWHAB, FTO, MMP14	DNA demethylation [BP], regulation of protein export from nucleus [BP], melanosome [CC], beta-tubulin binding [MF], cytoplasmic vesicle membrane [CC]
CG_adsipsc_promoter_p_PM_14_75_39			10	1.0	4.61E-05	CELF5, S100P, PQBP1, AKAP13, KLHDC1, GAS2L3, CMPK1, BSN, PCBP2, PRSS21, CDKN2C, PABPN1, HHEX, GTF2IRD1, TRIM69, IGHMBP2, CCDC113, FSCN3, COPS7A, TNK1, MTHFD1, ABI2, ARPC5L, CALML6, PRCD, TMEM216, AIFM3, MAD2L1BP, AGO1, TSN	cytoplasm [CC], poly(A)+ mRNA export from nucleus [BP]
CG_adsipsc_promoter_p_PM_12_5_9			2	0.4	1.63E-04	INPP5F, ACADS	butyrate catabolic process [BP], butyryl-CoA dehydrogenase activity [MF], phosphatidylinositol catabolic process [BP]
CG_adsipsc_promoter_p_PM_16_19_60			6	0.8	7.24E-05	SRSF3, PTPN11	phospholipase binding [MF]
CG_adsipsc_promoter_p_PM_12_345_14			1	0.2	5.56E-05	ADRA2C, LTC4S	leukotriene-C4 synthase activity [MF], negative regulation of uterine smooth muscle contraction [BP]
CG_adsipsc_promoter_p_PM_12_7_10			1	0.2	4.33E-05	MMP14	ovarian follicle development [BP]
CG_adsipsc_promoter_p_PM_16_2_201			6	1.0	6.23E-05	BPTF, PGAP2, ZRANB1, CRAMP1L, UNCX, WDR13, ZNF79, MMP23B, NPAS1, PDCD11, STRADB, ADAD2, LANCL2, ZNF383, DCK, NUSAP1, GRK5, CDC42SE2, PARD6B, SNRNP35, ZNF576, MALT1, ZNF578, MBNL1, PPP1R16B, HMG20B, SLIT2, BSPRY, GPI, ZMYM4, IFI35, ZNF687, TLE6, SETD8, CCRN4L, ATF5, CCDC155, ARID5B, CRCP, CD3EAP, MAF1, DDX42, SEPT7, TCF7L1, HEXDC, KPNA2, PLEKHA2, FTSJD2, HDAC11, ZNF775, RNF10, MLLT6, SNX1, FOXK2, PNRC2, FUBP3, CELF5, DES, KAT5, ZNF592, DMRTB1, TCEANC, EIF5A, NEK7, ZNF451, CABIN1, ZNF454, HAUS2, ZBTB8A, TBC1D23, PVRL2, PCBP2, UBXN2B, USP15, SENP6, TRPM4, GTF2I, THRSP, TXNRD1, MAU2, TICRR, DLD, CDC25B, UBE2E1, SENP2, CAPS, TRIP6, UBA2, MLL, CDK9, ZNF589, ING5, PARP3, BNIP1, ZNF382, UBE2I, GINS3, TAF5, ZNF37A, RPS6KA4, TAF1, RNASEH2B, TRNT1, BANP, CALML6, RBM25, CREM, ZNF501, IPO5, ZNF429, TRNAU1AP, WBSCR22, ZNF331, ZNF236, PAX2, SMAD1, MIB1, RPS7, MAPK15, IL37, PRKCSH, TIGD5, NHLH1, ZNF839, CD40, POLI, FUS, EHMT1, ATXN1L, DNAJB6, ZNF707, FHL1, STOX1, TCF25, UTP18, MVP, RPS27, NANOGNB, MSH3, SSX1, CHP1, RNF111, CRHBP, AIP, MLXIP, WHSC1, USPL1, MVB12A, TAOK2, MGST2, APOBEC3H, TRIOBP, ZNF524, TLK2, CRTC3, ID1, ZNF138, ZNF85, TBC1D13, PSMB4, MGRN1, PSMD9, CAMK1D, ZNF324, ARL2, JARID2, CLIC4, SSH3, SRRM4, HIST2H4B, IQGAP1, SRP54, PLEKHF1, NOP58, ECT2, GABARAPL2, RAD54L, PPP6R3, NPAS3, PTPRE, MLH1, ZFYVE16, LMCD1, ZFP42, MED15, NFATC2IP, ZNF586, PSMC2, NACC1, PPP2R5D, HSD17B6, MCM10, SNURF, PPM1E, GTF2H5, GTPBP4, MCM4, MCM2, ZNF391, GFI1B, NOTO, CCNB1, DDX27, NCK1, SPAST, ACTN4, TBC1D22B, MXI1, CALR, RPA1, OAZ3, ZNF713, SAE1, ZBTB43, ZNF90, ACTL6A, ZNF655, ATF4, COQ7, EWSR1, ZNF397, HIF3A	SUMO-specific protease activity [MF], cytoskeleton organization [BP], intracellular [CC], protein desumoylation [BP], protein sumoylation [BP], GTPase inhibitor activity [MF], nucleus [CC], intracellular membrane-bounded organelle [CC]
CG_adsipsc_promoter_p_PM_12_242_17			3	0.4	3.86E-05	SLC13A2, HELLS, HCK	centromeric heterochromatin assembly [BP], respiratory burst after phagocytosis [BP], low affinity sodium:dicarboxylate symporter activity [MF], leukocyte migration involved in immune response [BP]
CG_adsipsc_promoter_p_PM_12_483_13			2	0.4	5.43E-05	CLP1	siRNA loading onto RISC involved in RNA interference [BP]
CG_adsipsc_promoter_p_PM_12_282_11			2	0.4	9.88E-05	FAM20C, HMGA2, CNOT3, PFAS, WBP4, DCPS	histone H2A-S139 phosphorylation [BP], MH2 domain binding [MF], phosphoribosylformylglycinamidine synthase activity [MF], chromosome breakage [BP], MH1 domain binding [MF], mesodermal-endodermal cell signaling [BP], dentinogenesis [BP], mRNA cis splicing, via spliceosome [BP], negative regulation of double-strand break repair via nonhomologous end joining [BP], positive regulation of cellular response to X-ray [BP], nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [BP], osteoclast maturation [BP]
CG_adsipsc_promoter_p_PM_12_310_17			4	0.8	1.81E-05	RPS21, ACSF3	endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], malonyl-CoA synthetase activity [MF], endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], malonate catabolic process [BP]
CG_adsipsc_promoter_p_PM_14_81_24			4	0.6	2.22E-05	KDM6A, APOBEC3H, APOBEC3G	cytidine deamination [BP], negative regulation of viral reproduction [BP], DNA cytosine deamination [BP], negative regulation of transposition [BP], negative regulation of retroviral genome replication [BP], cytidine deaminase activity [MF], histone H3-K4 methylation [BP], negative regulation of viral genome replication [BP]
CG_adsipsc_promoter_p_PM_12_32_8			1	0.2	2.99E-04	PRKCB, CEACAM5, SLC22A1, AZU1, PPP1R3F	positive regulation of fractalkine biosynthetic process [BP], basolateral plasma membrane [CC], positive regulation of interleukin-1 beta biosynthetic process [BP], norepinephrine transmembrane transporter activity [MF], positive regulation of B cell receptor signaling pathway [BP], histone kinase activity (H3-T6 specific) [MF], glycogen binding [MF], histone H3-T6 phosphorylation [BP], acetylcholine transmembrane transporter activity [MF], establishment or maintenance of transmembrane electrochemical gradient [BP]
CG_adsipsc_promoter_p_PM_18_37_12			1	0.2	5.16E-05	PPARD, RXRA, ARID1A	maternal placenta development [BP], linoleic acid binding [MF], ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity [MF], steroid hormone receptor activity [MF], nucleosome mobilization [BP], embryo implantation [BP], intracellular receptor mediated signaling pathway [BP]
CG_adsipsc_promoter_p_PM_14_101_29			3	0.6	5.58E-05	MTHFD2, G6PC	phosphate ion binding [MF]
CG_adsipsc_promoter_p_PM_12_352_7			1	0.2	4.77E-06	IRF4, BHMT	betaine-homocysteine S-methyltransferase activity [MF], positive regulation of interleukin-13 biosynthetic process [BP], positive regulation of interleukin-10 biosynthetic process [BP], homocysteine S-methyltransferase activity [MF], positive regulation of interleukin-4 biosynthetic process [BP], amino-acid betaine catabolic process [BP], regulation of homocysteine metabolic process [BP]
CG_adsipsc_promoter_p_PM_14_84_15			2	1.0	1.26E-04	EGFR, MAP1S	activation of phospholipase A2 activity by calcium-mediated signaling [BP], actin filament binding [MF]
CG_adsipsc_promoter_p_PM_14_12_10			1	0.2	1.84E-05	KDM1A, COX10	protoheme IX farnesyltransferase activity [MF], heme O biosynthetic process [BP], regulation of primitive erythrocyte differentiation [BP]
CG_adsipsc_promoter_p_PM_12_163_7			2	0.4	3.32E-04	RPS15	ribosomal small subunit export from nucleus [BP]
CG_adsipsc_promoter_p_PM_14_49_6			1	0.2	9.24E-05	BMPR1A	mesendoderm development [BP], regulation of lateral mesodermal cell fate specification [BP], Mullerian duct regression [BP], paraxial mesoderm structural organization [BP], neural plate mediolateral regionalization [BP]
CG_adsipsc_promoter_p_PM_12_450_14			2	0.4	8.61E-05	WNT8B, TOM1L1, CHMP5, ZNRF2, LANCL2	negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway [BP], positive regulation of abscisic acid mediated signaling pathway [BP], endosome membrane [CC]
CG_adsipsc_promoter_p_PM_12_400_7			1	0.2	8.18E-05	ADCYAP1, SLC27A3	regulation of oligodendrocyte progenitor proliferation [BP], fatty-acyl-CoA synthase activity [MF], positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway [BP], negative regulation of acute inflammatory response to non-antigenic stimulus [BP], positive regulation of somatostatin secretion [BP], pituitary adenylate cyclase activating polypeptide activity [MF], pituitary adenylate cyclase-activating polypeptide receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_344_11			1	0.2	6.67E-06	UROD	uroporphyrinogen decarboxylase activity [MF]
CG_adsipsc_promoter_p_PM_12_55_17			3	0.6	1.15E-04	TBX1	vagus nerve morphogenesis [BP], positive regulation of tongue muscle cell differentiation [BP]
CG_adsipsc_promoter_p_PM_14_44_21			4	0.6	9.64E-06	SIN3B	Y chromosome [CC], autosome [CC]
CG_adsipsc_promoter_p_PM_18_43_161			4	0.8	4.63E-05	IMPA2, PIK3CA	phosphatidylinositol phosphorylation [BP]
CG_adsipsc_promoter_p_PM_16_34_17			2	0.4	7.15E-05	DNAJA3, MOV10L1, SUPV3L1, APEX1	NF-kappaB binding [MF], ATP-dependent RNA helicase activity [MF]
CG_adsipsc_promoter_p_PM_12_324_13			2	0.2	1.34E-04	WNT1, NLRX1, CYLD	midbrain-hindbrain boundary maturation during brain development [BP], negative regulation of type I interferon production [BP], cerebellum formation [BP], negative regulation of DNA damage checkpoint [BP]
CG_adsipsc_promoter_p_PM_12_268_16			2	0.4	4.43E-05	PKDCC	lung alveolus development [BP]
CG_adsipsc_promoter_p_PM_12_481_17			3	0.6	1.01E-05	IKBKG, HSP90AB1	UTP binding [MF], CTP binding [MF], nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [BP], sulfonylurea receptor binding [MF]
CG_adsipsc_promoter_p_PM_20_6_97			1	0.2	5.04E-05	BIRC5, AURKC, SIRT1, MIF, GSTP1, PPARA, ZNF473, PAFAH1B1, CPSF2, ADIPOQ, IGBP1	positive regulation of protein kinase A signaling cascade [BP], negative regulation of receptor biosynthetic process [BP], positive regulation of cAMP-dependent protein kinase activity [BP], negative regulation of stress-activated MAPK cascade [BP], chromosome passenger complex [CC], histone mRNA 3'-end processing [BP], platelet activating factor metabolic process [BP], negative regulation of tumor necrosis factor-mediated signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_15_10			2	0.4	1.60E-04	AKR1C4, ADRBK1, CPA2	negative regulation of the force of heart contraction by chemical signal [BP], chlordecone reductase activity [MF], vacuolar protein catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_350_9			2	0.2	1.41E-05	PRKCZ	positive regulation of interleukin-13 secretion [BP], positive regulation of interleukin-10 secretion [BP], positive regulation of T-helper 2 cell cytokine production [BP], positive regulation of interleukin-5 secretion [BP]
CG_adsipsc_promoter_p_PM_12_315_12			3	0.6	1.03E-04	KANK1, MOG	negative regulation of lamellipodium morphogenesis [BP], positive regulation of MyD88-dependent toll-like receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_421_7			2	0.4	5.15E-05	CPSF4	modification by virus of host mRNA processing [BP]
CG_adsipsc_promoter_p_PM_12_505_10			5	1.0	1.18E-04	GAA, DERA	maltose metabolic process [BP], sucrose metabolic process [BP], diaphragm contraction [BP], vacuolar sequestering [BP], deoxyribose-phosphate aldolase activity [MF]
CG_adsipsc_promoter_p_PM_12_311_8			1	0.2	1.13E-04	HGS, DENND3	endosome to lysosome transport [BP], endosomal transport [BP]
CG_adsipsc_promoter_p_PM_14_43_10			5	0.8	2.97E-05	MAG, TCF7L2, NCMAP	paranode region of axon [CC], regulation of myelination [BP], Schmidt-Lanterman incisure [CC]
CG_adsipsc_promoter_p_PM_12_162_10			2	0.4	1.55E-04	GNAS, ADSSL1	adenylosuccinate synthase activity [MF], post-embryonic body morphogenesis [BP], mu-type opioid receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_44_8			2	0.4	2.29E-04	PCK1, BMPR1A	glycerol biosynthetic process from pyruvate [BP], paraxial mesoderm structural organization [BP], neural plate mediolateral regionalization [BP]
CG_adsipsc_promoter_p_PM_12_2_9			3	0.6	1.81E-04	JRKL, ZKSCAN8, ZNF700, ZNF233, ZNF623, ZNF264, LTC4S, GLI4, ZNF586, ALOX15B, ZNF549, ZNF763, ZNF793	leukotriene metabolic process [BP], DNA binding [MF], leukotriene biosynthetic process [BP], zinc ion binding [MF]
CG_adsipsc_promoter_p_PM_12_284_10			3	0.6	9.72E-05	DOLPP1, LEP	dolichyldiphosphatase activity [MF], cellular response to L-ascorbic acid [BP], negative regulation of glutamine transport [BP]
CG_adsipsc_promoter_p_PM_18_17_48			1	0.2	2.93E-05	CTNNA1, RNF8, NDEL1, RIF1	oligopeptidase activity [MF], axon regeneration [BP], chromosome, telomeric region [CC]
CG_adsipsc_promoter_p_PM_18_3_54			4	0.8	8.78E-05	NADSYN1, QPRT	NAD metabolic process [BP], NAD biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_16_63_41			4	0.8	3.97E-05	SDHD, SDHC	mitochondrial respiratory chain complex II [CC], succinate dehydrogenase activity [MF], respiratory chain complex II [CC]
CG_adsipsc_promoter_p_PM_12_464_6			2	0.4	1.11E-04	GAA, PHKB, MYO6	glycogen catabolic process [BP], glutamate secretion [BP]
CG_adsipsc_promoter_p_PM_12_108_12			2	0.4	8.00E-05	PALM	dendritic spine membrane [CC], D3 dopamine receptor binding [MF], negative regulation of dopamine receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_330_8			3	0.6	1.58E-04	GPI	methylglyoxal biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_119_15			3	0.6	2.08E-05	HLA-G, ADIPOQ, RBM44	negative regulation of low-density lipoprotein particle receptor biosynthetic process [BP], response to linoleic acid [BP], detection of oxidative stress [BP], protein homodimerization activity [MF], negative regulation of metanephric mesenchymal cell migration [BP], positive regulation of cAMP-dependent protein kinase activity [BP], positive regulation of renal albumin absorption [BP], negative regulation of eukaryotic cell surface binding [BP], cellular response to epinephrine stimulus [BP], positive regulation of monocyte chemotactic protein-1 production [BP], positive regulation of metanephric glomerular visceral epithelial cell development [BP], positive regulation of myeloid cell apoptotic process [BP], negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_168_10			3	0.6	2.19E-05	BHLHA15, LTBP1, NAGLU	intracellular distribution of mitochondria [BP], sequestering of TGFbeta in extracellular matrix [BP], alpha-N-acetylglucosaminidase activity [MF]
CG_adsipsc_promoter_p_PM_12_238_17			2	0.4	1.96E-04	HMGA2, GRK1, HEXB	histone H2A-S139 phosphorylation [BP], MH2 domain binding [MF], photoreceptor cell morphogenesis [BP], regulation of rhodopsin mediated signaling pathway [BP], mesodermal-endodermal cell signaling [BP], male courtship behavior [BP], chromosome breakage [BP], MH1 domain binding [MF], oncogene-induced senescence [BP], negative regulation of double-strand break repair via nonhomologous end joining [BP], positive regulation of cellular response to X-ray [BP], post-embryonic retina morphogenesis in camera-type eye [BP]
CG_adsipsc_promoter_p_PM_12_429_7			1	0.2	1.18E-04	PIPOX	L-lysine catabolic process to acetyl-CoA via L-pipecolate [BP], L-pipecolate oxidase activity [MF], sarcosine oxidase activity [MF]
CG_adsipsc_promoter_p_PM_12_270_13			2	0.4	2.07E-04	ATM, ESPL1, CDC6, KIF15	mitotic anaphase [BP], mitosis [BP], spindle [CC]
CG_adsipsc_promoter_p_PM_14_9_16			3	0.6	7.03E-05	DDX3X, ATP2A2, GBAS	ATP biosynthetic process [BP], RNA secondary structure unwinding [BP], calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF]
CG_adsipsc_promoter_p_PM_12_264_10			3	0.6	3.45E-05	BCMO1	beta-carotene 15,15'-monooxygenase activity [MF], vitamin A biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_219_11			1	0.2	5.24E-05	RAD21L1, MYC, ATG10	autophagy in response to ER overload [BP], negative regulation of G2 phase of mitotic cell cycle [BP], positive regulation of metanephric cap mesenchymal cell proliferation [BP], attachment of telomeric heterochromatin to nuclear envelope [BP]
CG_adsipsc_promoter_p_PM_12_253_24			2	0.4	1.28E-04	ACADS	butyrate catabolic process [BP], butyryl-CoA dehydrogenase activity [MF]
CG_adsipsc_promoter_p_PM_12_412_12			2	0.4	6.34E-05	IL15	extrathymic T cell selection [BP]
CG_adsipsc_promoter_p_PM_12_472_12			2	0.4	2.46E-04	FOXF1, SEC61B	establishment of epithelial cell apical/basal polarity [BP], embryonic ectodermal digestive tract morphogenesis [BP], lateral mesodermal cell differentiation [BP], epidermal growth factor binding [MF], detection of wounding [BP], mesenchyme migration [BP], endoplasmic reticulum Sec complex [CC], epithelial cell differentiation involved in mammary gland alveolus development [BP], negative regulation of mast cell degranulation [BP], branching involved in open tracheal system development [BP], right lung morphogenesis [BP]
CG_adsipsc_promoter_p_PM_12_19_7			3	0.6	8.66E-05	ALG1	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_6_5			1	0.2	2.35E-05	NOXA1, SNX10, CD38	superoxide-generating NADPH oxidase activator activity [MF], extrinsic to endosome membrane [CC], NAD+ nucleosidase activity [MF]
CG_adsipsc_promoter_p_PM_12_290_8			3	0.6	5.16E-05	TCTN1, GNPAT, RHOQ	GBD domain binding [MF], central nervous system interneuron axonogenesis [BP], glycerone-phosphate O-acyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_129_9			2	0.4	9.88E-05	ATP6V1F, TMEM57	ATPase activity, uncoupled [MF], neuron projection terminus [CC]
CG_adsipsc_promoter_p_PM_14_115_11			2	0.4	2.69E-05	AGTR1, MXD1, DPH1	regulation of systemic arterial blood pressure by renin-angiotensin [BP], cell proliferation [BP]
CG_adsipsc_promoter_p_PM_16_18_29			2	0.4	2.74E-05	CRHR1, CREB1, SMAD3, WFS1	corticotropin-releasing hormone receptor activity [MF], protein stabilization [BP], activating transcription factor binding [MF], negative regulation of type B pancreatic cell apoptotic process [BP], RNA polymerase II activating transcription factor binding [MF], positive regulation of transforming growth factor beta3 production [BP]
CG_adsipsc_promoter_p_PM_12_489_16			2	0.4	4.56E-05	CCIN, SYNM	structural constituent of cytoskeleton [MF]
CG_adsipsc_promoter_p_PM_16_31_17			4	0.8	1.41E-04	RBX1	VCB complex [CC], Cul4B-RING ubiquitin ligase complex [CC]
CG_adsipsc_promoter_p_PM_14_21_7			1	0.2	1.52E-04	KIF25, GCDH, RAB33B, DNAH2	glutaryl-CoA dehydrogenase activity [MF], regulation of retrograde vesicle-mediated transport, Golgi to ER [BP], microtubule motor activity [MF]
CG_adsipsc_promoter_p_PM_12_39_9			2	0.4	1.31E-05	EP300, MUS81	3'-flap endonuclease activity [MF], lysine N-acetyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_420_6			1	0.2	1.67E-04	ZRANB1, ATCAY, POLR1B	protein deubiquitination involved in ubiquitin-dependent protein catabolic process [BP], negative regulation of glutamate metabolic process [BP], nucleologenesis [BP]
CG_adsipsc_promoter_p_PM_12_358_11			3	0.4	2.66E-04	PCDHGA12, PCDHGB7, PCDHGB5, GATAD2A, PCDHGA6, RPS6KA4	homophilic cell adhesion [BP], calcium ion binding [MF], histone H3-S28 phosphorylation [BP], histone H3-S10 phosphorylation [BP], anterior neuropore closure [BP]
CG_adsipsc_promoter_p_PM_12_194_12			2	0.4	9.39E-05	MDK	defecation [BP]
CG_adsipsc_promoter_p_PM_20_34_79			1	0.2	6.13E-05	FUS, FOXK1, YBEY, GAPDH, SHROOM2, XIAP, EDC4, SKI, POLH, GNL3, PPP1R7, SOX13, GADD45G, BSN, SCNN1B, ZNF765, IRAK3, ZBTB33, UTP18, RGS9, ISCU, ZBTB7B, TET1, CTSA, SOD1, MLXIP, PPP6R3, MDM4, CCND1, ZNF844, ZNF860, FOXA3, RUSC1, ZKSCAN5, ZNF501, TRIP4, SPHK1	ligand-gated sodium channel activity [MF], re-entry into mitotic cell cycle [BP], nucleus [CC]
CG_adsipsc_promoter_p_PM_14_14_6			1	0.2	2.97E-04	DLAT	dihydrolipoyllysine-residue acetyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_18_1_14			2	0.4	4.69E-05	KIAA1324	positive regulation of vacuole organization [BP], positive regulation of autophagic vacuole assembly [BP]
CG_adsipsc_promoter_p_PM_14_99_13			2	0.4	8.47E-05	NFATC4, ZNRF3, SDCBP, CDKN1B	cellular response to lithium ion [BP], frizzled binding [MF]
CG_adsipsc_promoter_p_PM_12_448_7			1	0.2	2.64E-05	OXA1L	mitochondrial proton-transporting ATP synthase complex assembly [BP], mitochondrial ribosome binding [MF]
CG_adsipsc_promoter_p_PM_12_356_14			1	0.2	9.33E-05	HNRNPA1L2, RPL38, NANOS3, RPS7, PUSL1, DDX49	RNA binding [MF]
CG_adsipsc_promoter_p_PM_12_195_13			1	0.2	2.74E-05	PRMT7, BASP1	[myelin basic protein]-arginine N-methyltransferase activity [MF], positive regulation of metanephric ureteric bud development [BP], thorax and anterior abdomen determination [BP], protein-arginine omega-N symmetric methyltransferase activity [MF], peptidyl-arginine methylation, to symmetrical-dimethyl arginine [BP]
CG_adsipsc_promoter_p_PM_18_36_60			4	0.8	4.21E-05	DUT, WNT9B, AK4, DRD4	tetracycline metabolic process [BP], dUTP diphosphatase activity [MF], carbon tetrachloride metabolic process [BP], olfactory learning [BP], establishment of planar polarity involved in nephron morphogenesis [BP], dUMP biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_470_20			5	0.8	4.60E-05	ESRRB, XYLB	trophectodermal cell proliferation [BP], xylulose catabolic process [BP], xylulokinase activity [MF]
CG_adsipsc_promoter_p_PM_12_437_13			2	0.4	1.15E-04	PRKAR2B	response to antipsychotic drug [BP]
CG_adsipsc_promoter_p_PM_12_379_8			2	0.4	7.26E-05	PAK2, APOC1, AKR1A1	D-glucuronate catabolic process [BP], negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [BP], negative regulation of phosphatidylcholine catabolic process [BP], L-ascorbic acid biosynthetic process [BP], L-glucuronate reductase activity [MF]
CG_adsipsc_promoter_p_PM_20_35_116			1	0.2	3.61E-05	ULK1, WIPI2	pre-autophagosomal structure membrane [CC]
CG_adsipsc_promoter_p_PM_12_100_9			3	0.6	1.28E-04	DDX20	spliceosomal complex [CC]
CG_adsipsc_promoter_p_PM_12_355_8			2	0.4	6.05E-05	TPCN1, RAB36	protein transport [BP], NAADP-sensitive calcium-release channel activity [MF]
CG_adsipsc_promoter_p_PM_12_485_4			2	0.4	1.16E-04	RPL15, PRLH, ZCCHC17, IGHMBP2, SRGN	ATP-dependent 5'-3' RNA helicase activity [MF], prolactin-releasing peptide receptor binding [MF], maintenance of granzyme B location in T cell secretory granule [BP], T cell secretory granule organization [BP], maintenance of protease location in mast cell secretory granule [BP], cytosolic large ribosomal subunit [CC]
CG_adsipsc_promoter_p_PM_20_5_106			1	0.2	4.68E-05	PRPF4B, RIPK1, ATP11B, HNRNPH3, HNRNPH2, MINK1, CDK12, CDK13, RBM25, GSG2, IRAK4, RPS24, TRIM28, HNRNPA3, PKN2, SCCPDH, TPH2, HPDL, CCND1, CCND2, SLC28A2, HSD3B7, ATP9B, MATR3	phosphorylation of RNA polymerase II C-terminal domain [BP], protein kinase activity [MF], aminophospholipid transport [BP], cyclin-dependent protein kinase holoenzyme complex [CC], aromatic amino acid family metabolic process [BP], nucleotide binding [MF], nucleoside binding [MF]
CG_adsipsc_promoter_p_PM_12_423_13			2	0.4	7.26E-05	SLC6A1, PRKAR2B, NTF3, BCO2, CNTN2	learning [BP], positive regulation of adenosine receptor signaling pathway [BP], regulation of synaptic transmission [BP], carotene metabolic process [BP], carotenoid metabolic process [BP], response to antipsychotic drug [BP], gamma-aminobutyric acid import [BP], establishment of protein localization to juxtaparanode region of axon [BP], carotene catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_31_10			3	0.6	4.53E-05	TXNDC17, PTX3, LAMP1, CACNB2	protein-disulfide reductase activity [MF], sarcolemma [CC], (1->3)-beta-D-glucan binding [MF], multivesicular body [CC]
CG_adsipsc_promoter_p_PM_12_42_12			4	0.8	3.98E-05	LAMA3, ITPKA	calmodulin-dependent protein kinase activity [MF], receptor binding [MF]
CG_adsipsc_promoter_p_PM_12_359_7			1	0.2	1.92E-04	TALDO1, SLC38A3	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF], asparagine transport [BP], histidine transport [BP], xylulose biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_213_6			1	0.2	1.38E-04	P2RX4, BMPER	endothelial cell activation [BP]
CG_adsipsc_promoter_p_PM_16_66_18			2	0.4	5.85E-05	GPD2, AGXT	oxalic acid secretion [BP], serine-pyruvate transaminase activity [MF], sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [MF]
CG_adsipsc_promoter_p_PM_12_283_9			2	0.4	4.02E-05	ENPEP, METTL14, CLEC3B	metalloaminopeptidase activity [MF], mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [MF], kringle domain binding [MF]
CG_adsipsc_promoter_p_PM_12_277_18			1	0.2	3.34E-04	F2	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_20_36_72			1	0.2	3.44E-05	SCGB2A1, TDRD9, MYH14, PRMT7, SHBG	DNA methylation involved in gamete generation [BP], androgen binding [MF], motor activity [MF]
CG_adsipsc_promoter_p_PM_12_466_19			3	0.6	1.23E-04	MPV17L, B3GALT6	negative regulation of hydrogen peroxide biosynthetic process [BP], galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_273_5			2	0.4	2.09E-04	PCDHGA9, PCDHGB7, PCDHGB5, PCDHGB4, PCDHGA6, PCDHGA12	homophilic cell adhesion [BP], calcium ion binding [MF], cell adhesion [BP]
CG_adsipsc_promoter_p_PM_16_65_13			1	0.2	1.61E-05	WNT9B	establishment of planar polarity involved in nephron morphogenesis [BP]
CG_adsipsc_promoter_p_PM_12_271_7			2	0.4	1.65E-04	FPGS	tetrahydrofolylpolyglutamate synthase activity [MF]
CG_adsipsc_promoter_p_PM_12_197_10			2	0.4	3.65E-04	CACNA1I	low voltage-gated calcium channel activity [MF]
CG_adsipsc_promoter_p_PM_12_443_6			2	0.4	1.42E-05	DPEP1, SERPINB12	metallodipeptidase activity [MF], cellular lactam catabolic process [BP], negative regulation of endopeptidase activity [BP]
CG_adsipsc_promoter_p_PM_14_40_6			1	0.2	5.23E-05	CARTPT	positive regulation of epinephrine secretion [BP]
CG_adsipsc_promoter_p_PM_12_208_10			2	0.4	7.32E-05	HLA-DQA2, P2RX7, CCL4	positive regulation of calcium ion transport [BP], phospholipid transfer to membrane [BP], NAD transport [BP], immune response [BP]
CG_adsipsc_promoter_p_PM_12_143_11			2	0.4	2.46E-04	JUNB, NUDT1	osteoblast proliferation [BP], ATP diphosphatase activity [MF]
CG_adsipsc_promoter_p_PM_12_180_7			1	0.2	7.51E-05	ATP2A2, CARKD, PARK7	positive regulation of oxidative phosphorylation uncoupler activity [BP], calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential [MF], ATP-dependent NAD(P)H-hydrate dehydratase activity [MF]
CG_adsipsc_promoter_p_PM_16_20_22			6	0.8	1.13E-04	RALY, CDC5L	catalytic step 2 spliceosome [CC], WD40-repeat domain binding [MF]
CG_adsipsc_promoter_p_PM_14_61_8			2	0.4	2.49E-05	SMARCA4, NCR1, HEPHL1, CUTC, PRMT7	histone binding [MF], copper ion transport [BP], SWI/SNF complex [CC]
CG_adsipsc_promoter_p_PM_20_12_100			1	0.2	6.18E-05	STK11, MAPK8IP2, RNF40, UBE2A	HULC complex [CC], protein kinase activator activity [MF]
CG_adsipsc_promoter_p_PM_12_441_6			2	0.4	7.74E-05	SDHD	mitochondrial electron transport, succinate to ubiquinone [BP]
CG_adsipsc_promoter_p_PM_14_108_7			1	0.2	2.98E-05	RCL1	RNA-3'-phosphate cyclase activity [MF]
CG_adsipsc_promoter_p_PM_12_173_7			2	0.4	3.17E-05	LRSAM1, FDFT1	farnesyl-diphosphate farnesyltransferase activity [MF], squalene synthase activity [MF], ubiquitin-dependent endocytosis [BP]
CG_adsipsc_promoter_p_PM_14_48_4			1	0.2	3.57E-05	SHROOM2	eye pigment granule organization [BP]
CG_adsipsc_promoter_p_PM_12_184_9			2	0.4	1.78E-04	MDM2	cellular response to vitamin B1 [BP], cellular response to UV-C [BP]
CG_adsipsc_promoter_p_PM_12_295_12			2	0.4	1.03E-04	GAPDH	peptidyl-cysteine S-nitrosylase activity [MF], peptidyl-cysteine S-trans-nitrosylation [BP], glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [MF]
CG_adsipsc_promoter_p_PM_12_149_21			2	0.4	1.52E-04	ADCYAP1	positive regulation of somatostatin secretion [BP], pituitary adenylate cyclase-activating polypeptide receptor binding [MF], pituitary adenylate cyclase activating polypeptide activity [MF], negative regulation of acute inflammatory response to non-antigenic stimulus [BP]
CG_adsipsc_promoter_p_PM_12_353_5			2	0.4	4.67E-06	SLC50A1, AGBL5	protein branching point deglutamylation [BP], glucoside transport [BP], glucoside transmembrane transporter activity [MF]
CG_adsipsc_promoter_p_PM_20_19_79			1	0.2	5.54E-05	HMGB3, FOXR1, FOXR2, GLI1, FOXO4, FOXK1	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF], double-stranded DNA binding [MF], DNA binding, bending [MF]
CG_adsipsc_promoter_p_PM_16_50_18			3	0.6	5.29E-05	BCMO1	beta-carotene 15,15'-monooxygenase activity [MF], vitamin A biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_186_9			2	0.4	7.55E-05	GNAS	post-embryonic body morphogenesis [BP]
CG_adsipsc_promoter_p_PM_12_401_5			1	0.2	6.15E-05	COG2, GOSR1, MGST2	leukotriene-C4 synthase activity [MF], intra-Golgi vesicle-mediated transport [BP]
CG_adsipsc_promoter_p_PM_12_391_13			2	0.4	7.25E-05	BANP, SYNE2	protein localization to nucleus [BP]
CG_adsipsc_promoter_p_PM_12_302_13			3	0.6	3.96E-05	RAB10, RIMKLA	N-acetyl-L-aspartate-L-glutamate ligase activity [MF], establishment of protein localization to endoplasmic reticulum membrane [BP]
CG_adsipsc_promoter_p_PM_12_387_7			3	0.6	1.49E-04	UROD	uroporphyrinogen decarboxylase activity [MF]
CG_adsipsc_promoter_p_PM_18_7_50			4	0.8	4.87E-05	IPO11, NUP205, IPO5	ribosomal protein import into nucleus [BP], nuclear pore [CC]
CG_adsipsc_promoter_p_PM_12_121_6			2	0.4	1.91E-04	RAB7A, PML	epidermal growth factor catabolic process [BP], negative regulation of translation in response to oxidative stress [BP], extrinsic to endoplasmic reticulum membrane [CC]
CG_adsipsc_promoter_p_PM_12_351_8			1	0.2	1.67E-04	DAG1, STXBP2	nerve maturation [BP], syntaxin-3 binding [MF]
CG_adsipsc_promoter_p_PM_12_166_5			1	0.2	1.63E-04	EXO1, DNASE1	double-stranded DNA specific 5'-3' exodeoxyribonuclease activity [MF], deoxyribonuclease I activity [MF]
CG_adsipsc_promoter_p_PM_18_28_30			3	0.6	5.37E-05	APOBEC3H, APOBEC3G	cytidine deamination [BP], negative regulation of retroviral genome replication [BP], DNA cytosine deamination [BP], negative regulation of transposition [BP], cytidine deaminase activity [MF]
CG_adsipsc_promoter_p_PM_12_135_18			2	0.4	2.84E-04	DIO3, NIT2	thyroxine 5-deiodinase activity [MF], omega-amidase activity [MF]
CG_adsipsc_promoter_p_PM_16_55_20			2	0.4	6.62E-05	KDM1B	histone demethylase activity (H3-monomethyl-K4 specific) [MF]
CG_adsipsc_promoter_p_PM_12_127_9			1	0.2	2.97E-05	HNF1A	renal glucose absorption [BP]
CG_adsipsc_promoter_p_PM_12_164_7			1	0.2	2.14E-04	AK5	dADP biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_396_12			2	0.4	2.60E-05	ICAM1	response to sulfur dioxide [BP], T cell antigen processing and presentation [BP]
CG_adsipsc_promoter_p_PM_12_11_20			2	0.4	1.60E-04	IKBKG, KIT, CDK1	activation of MAPK activity [BP]
CG_adsipsc_promoter_p_PM_12_508_11			2	0.4	8.46E-05	NCBP1	regulation of translational initiation [BP]
CG_adsipsc_promoter_p_PM_20_20_100			1	0.2	5.11E-05	PKD2, SIRT1, RIPK2, AACS	positive regulation of immature T cell proliferation [BP], cellular response to testosterone stimulus [BP], HLH domain binding [MF]
CG_adsipsc_promoter_p_PM_12_123_5			1	0.2	1.86E-04	SUFU	spinal cord dorsal/ventral patterning [BP]
CG_adsipsc_promoter_p_PM_12_317_11			1	0.2	2.71E-04	NAT8L, ZMIZ1	vitellogenesis [BP], aspartate N-acetyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_368_10			2	0.4	1.70E-05	CARKD, AQP6	ATP-dependent NAD(P)H-hydrate dehydratase activity [MF], nitrate transmembrane transporter activity [MF]
CG_adsipsc_promoter_p_PM_12_141_11			2	0.4	1.57E-04	SPHK1, CBR1, NUDT1, ABCG1	prostaglandin-E2 9-reductase activity [MF], sterol-transporting ATPase activity [MF], detection of hormone stimulus [BP], ATP diphosphatase activity [MF], 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [MF], sphingoid catabolic process [BP]
CG_adsipsc_promoter_p_PM_12_486_19			2	0.4	8.63E-05	TTYH1, ANO1, GABRQ	chloride channel complex [CC], chloride channel activity [MF]
CG_adsipsc_promoter_p_PM_20_29_148			1	0.2	8.30E-05	SERPINE1, ADIPOQ, LRP1	negative regulation of smooth muscle cell migration [BP]
CG_adsipsc_promoter_p_PM_14_42_9			3	0.6	2.02E-05	SUZ12, JARID2	ESC/E(Z) complex [CC]
CG_adsipsc_promoter_p_PM_12_254_16			2	0.4	5.22E-05	APAF1	apoptosome [CC]
CG_adsipsc_promoter_p_PM_16_59_29			6	1.0	4.69E-05	ALDH2, INPPL1	alcohol metabolic process [BP], inositol trisphosphate metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_388_6			1	0.2	4.05E-05	MAPT, NDEL1, SSH3	oligopeptidase activity [MF], axon cargo transport [BP], regulation of axonogenesis [BP], positive regulation of axon extension [BP]
CG_adsipsc_promoter_p_PM_12_96_9			1	0.2	6.55E-05	MTHFD1	methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [MF]
CG_adsipsc_promoter_p_PM_14_34_19			1	0.2	8.63E-06	RCC1, TUBG1, SNRPE, SRRM1	termination of RNA polymerase II transcription [BP], condensed nuclear chromosome [CC], spindle assembly [BP]
CG_adsipsc_promoter_p_PM_12_428_4			1	0.2	1.63E-05	GARS	diadenosine tetraphosphate biosynthetic process [BP], glycyl-tRNA aminoacylation [BP], glycine-tRNA ligase activity [MF]
CG_adsipsc_promoter_p_PM_16_32_47			4	0.8	3.65E-05	ATF1, MAP2K6, RPS6KA1	toll-like receptor 3 signaling pathway [BP], toll-like receptor 2 signaling pathway [BP], toll-like receptor 1 signaling pathway [BP], MyD88-dependent toll-like receptor signaling pathway [BP], MyD88-independent toll-like receptor signaling pathway [BP], TRIF-dependent toll-like receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_20_30_80			1	0.2	4.38E-05	RBM38, NLRP3, RBM10	3'-UTR-mediated mRNA stabilization [BP], detection of biotic stimulus [BP]
CG_adsipsc_promoter_p_PM_12_463_6			1	0.2	2.31E-04	MPST	3-mercaptopyruvate sulfurtransferase activity [MF], cyanate catabolic process [BP]
CG_adsipsc_promoter_p_PM_18_41_41			2	0.4	5.89E-05	APPL1, COG1, TMED2, CDC42, RARA	protein kinase B binding [MF], Golgi organization [BP]
CG_adsipsc_promoter_p_PM_12_484_11			2	0.4	2.31E-05	IL21R	interleukin-21-mediated signaling pathway [BP], interleukin-21 receptor activity [MF]
CG_adsipsc_promoter_p_PM_12_445_13			2	0.4	5.65E-05	MTM1, IDUA, PIAS4, ARHGEF7, DNAJA3	positive regulation of apoptotic process [BP], negative regulation of NF-kappaB transcription factor activity [BP], L-iduronidase activity [MF], phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [MF]
CG_adsipsc_promoter_p_PM_12_362_11			4	0.8	9.34E-05	NOS3, GIGYF2, EVC, DLK1, AHSG, P2RX2, CHST11	cadmium ion binding [MF], endochondral bone growth [BP], post-embryonic development [BP], skeletal system development [BP]
CG_adsipsc_promoter_p_PM_12_94_6			2	0.4	1.30E-04	MGAT3, MPI, INHA	inhibin A complex [CC], beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [MF], protein N-linked glycosylation via asparagine [BP]
CG_adsipsc_promoter_p_PM_12_406_8			1	0.2	6.73E-05	DNAAF1, RIPK1	regulation of cilium beat frequency [BP], regulation of ATP:ADP antiporter activity [BP]
CG_adsipsc_promoter_p_PM_12_237_11			3	0.6	3.82E-05	RAD54L2, SPDYA	protein kinase binding [MF]
CG_adsipsc_promoter_p_PM_12_99_10			1	0.2	7.12E-05	SAT1, AGBL5, MAPK8IP1, FKBP4	protein branching point deglutamylation [BP], spermidine binding [MF], axonal growth cone [CC], steroid hormone receptor complex assembly [BP], dentate gyrus mossy fiber [CC]
CG_adsipsc_promoter_p_PM_12_479_10			3	0.6	7.70E-05	SNTB2, KIF2A, PIK3CG, LAT, MAPRE1, INCENP	mitotic prometaphase [BP], microtubule [CC], mast cell degranulation [BP]
CG_adsipsc_promoter_p_PM_12_105_10			2	0.4	1.22E-04	POP4, CTU2	tRNA processing [BP], tRNA thio-modification [BP], ribonuclease MRP complex [CC]
CG_adsipsc_promoter_p_PM_12_427_7			2	0.4	1.00E-04	CCAR1, ZMIZ2	ligand-dependent nuclear receptor transcription coactivator activity [MF]
CG_adsipsc_promoter_p_PM_12_262_10			1	0.2	7.65E-06	MLXIP	mitochondrial outer membrane [CC]
CG_adsipsc_promoter_p_PM_12_320_11			3	0.6	1.32E-04	ETFDH, DDX11, POLD1	4 iron, 4 sulfur cluster binding [MF]
CG_adsipsc_promoter_p_PM_12_34_7			3	0.6	8.38E-06	HCK, KIAA1804, SNTG1	protein tyrosine kinase activity [MF], respiratory burst after phagocytosis [BP], protein autophosphorylation [BP], syntrophin complex [CC], leukocyte migration involved in immune response [BP]
CG_adsipsc_promoter_p_PM_14_90_13			4	0.8	4.71E-05	LIN28B, LAMP1, PCSK9	late endosome [CC], RNA 3'-end processing [BP]
CG_adsipsc_promoter_p_PM_16_37_42			4	0.8	4.92E-05	EP300, SMYD1, HIF1AN	regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP], positive regulation of myoblast differentiation [BP]
CG_adsipsc_promoter_p_PM_12_189_16			3	0.6	1.05E-04	C5AR1, GLYCTK, STAT5A	glycerate kinase activity [MF], complement receptor mediated signaling pathway [BP], positive regulation of mast cell differentiation [BP], complement component C5a binding [MF]
CG_adsipsc_promoter_p_PM_14_2_22			4	0.6	1.55E-05	PSMD4	mRNA metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_343_22			2	0.4	4.70E-05	DNAAF1	regulation of cilium beat frequency [BP]
CG_adsipsc_promoter_p_PM_12_9_15			7	0.8	1.61E-04	TRIB2, MSX2	negative regulation of fat cell differentiation [BP]
CG_adsipsc_promoter_p_PM_12_220_10			1	0.2	1.45E-04	SLC6A6, CYP2F1, ITPA	naphthalene metabolic process [BP], ITP catabolic process [BP], trichloroethylene metabolic process [BP], taurine:sodium symporter activity [MF], taurine transport [BP]
CG_adsipsc_promoter_p_PM_12_156_11			4	0.6	1.47E-04	WNT8A, IL4, VCAM1, KMO	negative regulation of T-helper 17 cell differentiation [BP], interleukin-4 receptor binding [MF], chronic inflammatory response [BP], polarity specification of anterior/posterior axis [BP], connective tissue growth factor biosynthetic process [BP], kynurenine 3-monooxygenase activity [MF]
CG_adsipsc_promoter_p_PM_20_3_121			1	0.2	8.16E-05	RAD17	DNA damage checkpoint [BP]
CG_adsipsc_promoter_p_PM_20_10_142			1	0.2	2.61E-05	TOR1B, SWSAP1, SUZ12, RBBP4, RAD54L	double-strand break repair via homologous recombination [BP], ESC/E(Z) complex [CC], nucleoside-triphosphatase activity [MF]
CG_adsipsc_promoter_p_PM_12_469_14			3	0.6	4.55E-05	PARD6B, PDZD3	apical part of cell [CC]
CG_adsipsc_promoter_p_PM_12_217_15			2	0.4	2.55E-04	PAQR5, CPS1, BRCA2	oogenesis [BP], BRCA2-MAGE-D1 complex [CC], carbamoyl-phosphate synthase (ammonia) activity [MF]
CG_adsipsc_promoter_p_PM_14_118_8			1	0.2	1.28E-05	RBBP8, FGFR3, PHGDH, SPHK1	substantia nigra development [BP], D-erythro-sphingosine kinase activity [MF], alveolar secondary septum development [BP], blastocyst hatching [BP], brain development [BP], axonogenesis involved in innervation [BP], positive regulation of protein ubiquitination [BP], sphinganine kinase activity [MF], sphingoid catabolic process [BP], phosphoglycerate dehydrogenase activity [MF], glial cell development [BP], DNA double-strand break processing involved in repair via single-strand annealing [BP]
CG_adsipsc_promoter_p_PM_12_128_12			2	0.4	5.67E-05	PROM2, EVC	cilium membrane [CC]
CG_adsipsc_promoter_p_PM_12_209_22			2	0.4	5.07E-05	STK11, CDKN1B	negative regulation of epithelial cell proliferation involved in prostate gland development [BP]
CG_adsipsc_promoter_p_PM_12_64_8			3	0.6	1.82E-04	NADSYN1, TPCN2, CACNG7, CR1	voltage-gated calcium channel activity [MF], complement component C3b receptor activity [MF], positive regulation of serine-type endopeptidase activity [BP], NAD+ synthase (glutamine-hydrolyzing) activity [MF], negative regulation of complement activation, alternative pathway [BP], complement component C4b receptor activity [MF], complement component C3b binding [MF], negative regulation of serine-type endopeptidase activity [BP], complement component C4b binding [MF], negative regulation of complement activation, classical pathway [BP]
CG_adsipsc_promoter_p_PM_12_460_6			4	0.6	8.50E-05	IL18BP	interleukin-18 binding [MF]
CG_adsipsc_promoter_p_PM_12_327_9			2	0.4	1.33E-04	AZU1, DISP1	positive regulation of fractalkine biosynthetic process [BP], positive regulation of interleukin-1 beta biosynthetic process [BP], patched ligand maturation [BP]
CG_adsipsc_promoter_p_PM_12_83_13			2	0.4	1.55E-04	RGN	gluconolactonase activity [MF]
CG_adsipsc_promoter_p_PM_14_87_14			3	0.6	4.74E-05	ZNF143, POLR3F	regulation of transcription from RNA polymerase III promoter [BP]
CG_adsipsc_promoter_p_PM_16_47_25			4	0.8	6.48E-05	EIF4B, RBM4, IREB2, EIF4EBP1	negative regulation of translational initiation [BP], regulation of translational initiation [BP], regulation of translation [BP]
CG_adsipsc_promoter_p_PM_16_6_19			3	0.6	9.98E-05	ACR	acrosome matrix dispersal [BP], amidase activity [MF]
CG_adsipsc_promoter_p_PM_12_53_7			2	0.4	2.12E-04	GLI1, SLC6A5, SLC1A4	L-hydroxyproline transmembrane transporter activity [MF], proline transmembrane transport [BP], glycine:sodium symporter activity [MF], notochord regression [BP], threonine transport [BP], L-threonine transmembrane transporter activity [MF], hydroxyproline transport [BP]
CG_adsipsc_promoter_p_PM_20_13_73			1	0.2	4.72E-05	CNST, WDYHV1, MPG	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], depurination [BP], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF], positive regulation of Golgi to plasma membrane protein transport [BP], protein-N-terminal glutamine amidohydrolase activity [MF]
CG_adsipsc_promoter_p_PM_12_408_10			1	0.2	1.63E-05	IGHMBP2	ATP-dependent 5'-3' DNA helicase activity [MF], ATP-dependent 5'-3' RNA helicase activity [MF]
CG_adsipsc_promoter_p_PM_12_506_10			2	0.4	1.51E-04	PSMD3, ADCYAP1, KNG1	enzyme regulator activity [MF], vasodilation [BP], pituitary adenylate cyclase-activating polypeptide receptor binding [MF], negative regulation of acute inflammatory response to non-antigenic stimulus [BP], positive regulation of somatostatin secretion [BP], pituitary adenylate cyclase activating polypeptide activity [MF], negative regulation of blood coagulation [BP]
CG_adsipsc_promoter_p_PM_12_260_17			4	0.6	6.93E-05	LRRC8A	pre-B cell differentiation [BP]
CG_adsipsc_promoter_p_PM_14_116_12			4	0.8	1.73E-05	RAB8A	Golgi vesicle fusion to target membrane [BP]
CG_adsipsc_promoter_p_PM_14_37_17			5	0.8	3.97E-05	RLF	DNA mediated transformation [BP]
CG_adsipsc_promoter_p_PM_12_192_10			2	0.4	3.78E-05	ASF1A, TALDO1, ALPL	sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF], histone binding [MF], cementum mineralization [BP], xylulose biosynthetic process [BP]
CG_adsipsc_promoter_p_PM_12_389_25			3	0.6	1.53E-05	USP14	tRNA guanylyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_18_33_23			1	0.2	6.78E-05	VASH1, NCAPD2	negative regulation of lymphangiogenesis [BP], condensin core heterodimer [CC]
CG_adsipsc_promoter_p_PM_12_98_8			4	0.8	1.28E-04	FZD10, NQO2, GPR34, OR4F5, OR5K4	dihydronicotinamide riboside quinone reductase activity [MF], G-protein coupled receptor activity [MF]
CG_adsipsc_promoter_p_PM_12_446_8			2	0.4	1.57E-04	MARC2	nitrate reductase activity [MF]
CG_adsipsc_promoter_p_PM_12_435_10			1	0.2	3.72E-04	SUOX, SLC6A8	creatine transmembrane transporter activity [MF], sulfite oxidase activity [MF], creatine:sodium symporter activity [MF]
CG_adsipsc_promoter_p_PM_12_10_12			2	0.4	1.77E-04	MYLPF, SLC27A2, SMTN	phytanate-CoA ligase activity [MF], pristanate-CoA ligase activity [MF], structural constituent of muscle [MF]
CG_adsipsc_promoter_p_PM_12_71_7			2	0.4	5.88E-05	GATAD2A, NAGK, RGCC, OS9	Hrd1p ubiquitin ligase complex [CC], positive regulation of extracellular matrix constituent secretion [BP], regulation of M/G1 transition of mitotic cell cycle [BP], N-acetylglucosamine kinase activity [MF], N-acetylmannosamine metabolic process [BP], anterior neuropore closure [BP], negative regulation of exit from mitosis [BP], negative regulation of fibroblast growth factor production [BP], positive regulation of gene expression involved in extracellular matrix organization [BP]
CG_adsipsc_promoter_p_PM_12_67_11			2	0.4	1.35E-04	ZNF205, TFAP2C	dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [BP], positive regulation of hydrogen peroxide biosynthetic process [BP], positive regulation of mitochondrial outer membrane permeabilization [BP]
CG_adsipsc_promoter_p_PM_16_62_64			5	1.0	5.83E-05	JUNB, MX2, VHL, GMNN, PIN1, KIF2C, GNL3, SRSF3, USB1, CDK12, POR, GPNMB, SON, POLD1, ING1, GLI1, RELB, CENPO, ATM, TRIM28, STAG2, CHMP1B, SNRPF, CTNNA1, MCM8, SNRPB2, SNRPD3, SNRPD1, ZNF593, CCND1, GEMIN6, STK36, CTCF, PPP2R5C, TNKS	spliceosomal snRNP assembly [BP], cell cycle [BP], osteoblast differentiation [BP], chromosome, centromeric region [CC], positive regulation of smoothened signaling pathway [BP], small nuclear ribonucleoprotein complex [CC], U12-type spliceosomal complex [CC], RNA splicing [BP], nucleoplasm [CC], histone mRNA metabolic process [BP], transcription corepressor activity [MF], regulation of smoothened signaling pathway [BP], regulation of cell cycle [BP]
CG_adsipsc_promoter_p_PM_14_95_13			1	0.2	3.96E-05	PQBP1	neuronal ribonucleoprotein granule [CC]
CG_adsipsc_promoter_p_PM_12_329_14			2	0.4	1.31E-05	ANO6, KIR2DL3, KIR2DL1, PHGDH, KIR2DL4, KIR2DS4, FCAR	natural killer cell inhibitory signaling pathway [BP], integral to plasma membrane [CC], IgA binding [MF], phosphatidylserine exposure on blood platelet [BP], phosphoglycerate dehydrogenase activity [MF]
CG_adsipsc_promoter_p_PM_12_68_7			2	0.4	7.83E-05	CENPA, RBBP4, KIT	erythropoietin-mediated signaling pathway [BP], melanocyte migration [BP], Kit signaling pathway [BP], nucleosome assembly [BP], chromatin remodeling [BP], CENP-A containing nucleosome assembly at centromere [BP], chromatin assembly [BP], stem cell factor receptor activity [MF], melanocyte adhesion [BP]
CG_adsipsc_promoter_p_PM_12_303_6			2	0.4	1.18E-04	ETFDH	oxidoreductase activity, oxidizing metal ions with flavin as acceptor [MF]
CG_adsipsc_promoter_p_PM_12_79_20			3	0.6	1.55E-04	PRMT7	[myelin basic protein]-arginine N-methyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_88_13			4	0.6	1.32E-04	S100A1, TPM1, GRK1, SPHK1	regulation of rhodopsin mediated signaling pathway [BP], sphingoid catabolic process [BP], positive regulation of heart rate by epinephrine [BP], sarcoplasmic reticulum [CC]
CG_adsipsc_promoter_p_PM_12_130_11			1	0.2	1.31E-04	RAB5A	positive regulation of exocytosis [BP]
CG_adsipsc_promoter_p_PM_12_145_11			2	0.4	5.05E-05	TNFRSF12A, ULK1	radial glia guided migration of cerebellar granule cell [BP], axon extension [BP], substrate-dependent cell migration, cell attachment to substrate [BP]
CG_adsipsc_promoter_p_PM_14_62_31			3	0.6	7.01E-05	GAA, SLC3A2	diaphragm contraction [BP], sucrose metabolic process [BP], tryptophan transport [BP], maltose metabolic process [BP], vacuolar sequestering [BP], leucine import [BP], maltose alpha-glucosidase activity [MF]
CG_adsipsc_promoter_p_PM_12_245_10			2	0.4	9.08E-05	AQP1	maintenance of symbiont-containing vacuole by host [BP], carbon dioxide transmembrane transport [BP], nitric oxide transmembrane transporter activity [MF], carbon dioxide transmembrane transporter activity [MF], transepithelial water transport [BP]
CG_adsipsc_promoter_p_PM_12_249_6			3	0.6	4.75E-04	PDE3A	cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [MF], positive regulation of oocyte development [BP]
CG_adsipsc_promoter_p_PM_18_32_106			4	0.8	6.39E-05	CNNM2, ZDHHC17	magnesium ion transport [BP]
CG_adsipsc_promoter_p_PM_12_175_14			4	0.6	1.34E-04	NLGN3, PNLIPRP2	galactolipase activity [MF], regulation of terminal button organization [BP]
CG_adsipsc_promoter_p_PM_12_498_7			1	0.2	3.40E-05	NAT2	arylamine N-acetyltransferase activity [MF]
CG_adsipsc_promoter_p_PM_12_384_4			2	0.4	6.93E-05	EGR1	positive regulation of glomerular metanephric mesangial cell proliferation [BP], cellular response to isoquinoline alkaloid [BP], response to norepinephrine stimulus [BP], cellular response to mycophenolic acid [BP]
CG_adsipsc_promoter_p_PM_14_3_20			4	0.6	2.80E-05	XPOT, ACSS2	tRNA export from nucleus [BP], acetyl-CoA biosynthetic process from acetate [BP]
CG_adsipsc_promoter_p_PM_12_236_9			2	0.4	1.88E-04	MAS1, HTT, PCK1	diazepam binding [MF], response to activity [BP]
CG_adsipsc_promoter_p_PM_12_48_11			3	0.4	1.01E-04	FKTN, COG3	cis-Golgi network [CC]
CG_adsipsc_promoter_p_PM_12_342_9			1	0.2	2.53E-05	WFS1, PTPN11	negative regulation of growth hormone secretion [BP], polyubiquitinated misfolded protein transport [BP], glucose homeostasis [BP], negative regulation of type B pancreatic cell apoptotic process [BP], negative regulation of cortisol secretion [BP]
CG_adsipsc_promoter_p_PM_12_346_11			1	0.2	2.74E-05	NQO2	dihydronicotinamide riboside quinone reductase activity [MF], NADPH dehydrogenase (quinone) activity [MF]
CG_adsipsc_promoter_p_PM_20_16_100			1	0.2	2.90E-05	WNT8A	polarity specification of anterior/posterior axis [BP]
CG_adsipsc_promoter_p_PM_14_77_15			7	1.0	6.15E-05	SPIRE2, MAVS, RIC8B, RAB10	cell cortex [CC], positive regulation of IP-10 production [BP], establishment of protein localization to endoplasmic reticulum membrane [BP]
CG_adsipsc_promoter_p_PM_12_340_8			2	0.4	1.47E-04	SLC6A19	neutral amino acid transmembrane transporter activity [MF]
CG_adsipsc_promoter_p_PM_12_148_10			3	0.6	1.50E-04	MIA3, GTPBP4, ALOX15B	negative regulation of cell migration [BP]
CG_adsipsc_promoter_p_PM_12_177_9			1	0.2	7.80E-05	SELV, CAPN3, AIP, SELT	autolysis [BP], cell redox homeostasis [BP], selenium binding [MF], GAF domain binding [MF], G1 to G0 transition involved in cell differentiation [BP]
CG_adsipsc_promoter_p_PM_12_272_18			2	0.4	2.43E-05	CCNY	positive regulation of cyclin-dependent protein kinase activity [BP]
CG_adsipsc_promoter_p_PM_12_95_7			1	0.2	1.28E-04	MAT2B	methionine adenosyltransferase regulator activity [MF], extracellular polysaccharide biosynthetic process [BP], dTDP-4-dehydrorhamnose reductase activity [MF], methionine adenosyltransferase complex [CC]
CG_adsipsc_promoter_p_PM_12_50_5			2	0.4	1.05E-04	CDH5, CNDP1, CLDN20	tight junction [CC], tripeptidase activity [MF]
CG_adsipsc_promoter_p_PM_12_116_14			3	0.6	1.19E-04	MAPK8IP1	dentate gyrus mossy fiber [CC]
CG_adsipsc_promoter_p_PM_12_261_8			2	0.4	9.18E-05	SRSF3, NUP107, PLOD1	hydroxylysine biosynthetic process [BP], mRNA export from nucleus [BP]
CG_adsipsc_promoter_p_PM_12_14_10			2	0.4	1.19E-04	ALDH5A1	acetate metabolic process [BP], succinate-semialdehyde dehydrogenase (NAD+) activity [MF], gamma-aminobutyric acid catabolic process [BP], succinate-semialdehyde dehydrogenase [NAD(P)+] activity [MF]
CG_adsipsc_promoter_p_PM_12_23_13			2	0.4	1.15E-04	STXBP5	positive regulation of exocytosis [BP]
CG_adsipsc_promoter_p_PM_14_51_7			1	0.2	1.12E-04	PPP2R4	protein tyrosine phosphatase activator activity [MF]
CG_adsipsc_promoter_p_PM_12_246_4			2	0.4	5.68E-05	WDYHV1, AGBL5	protein branching point deglutamylation [BP], protein-N-terminal glutamine amidohydrolase activity [MF]
CG_adsipsc_promoter_p_PM_12_267_10			3	0.4	1.77E-04	CASP8	Noc1p-Noc2p complex [CC]
CG_adsipsc_promoter_p_PM_12_348_8			2	0.4	2.05E-05	BGN, B3GNT3, PROZ	Golgi lumen [CC], glycosaminoglycan metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_241_11			2	0.4	1.02E-04	ADORA1, LIPG, PLCH2	lipid catabolic process [BP], phospholipase activity [MF]
CG_adsipsc_promoter_p_PM_14_131_15			4	0.8	1.04E-04	MOCS3	tRNA thio-modification [BP], URM1 activating enzyme activity [MF], enzyme active site formation via L-cysteine persulfide [BP]
CG_adsipsc_promoter_p_PM_12_244_8			1	0.2	1.27E-04	ADCY1, SLC24A3	calcium, potassium:sodium antiporter activity [MF], calcium- and calmodulin-responsive adenylate cyclase activity [MF]
CG_adsipsc_promoter_p_PM_14_53_6			2	0.4	9.11E-05	PGAM1, CORO1A	negative regulation of actin nucleation [BP], regulation of pentose-phosphate shunt [BP]
CG_adsipsc_promoter_p_PM_12_201_5			2	0.4	1.87E-04	SYNE2, TERF2IP, PPP1R3F	negative regulation of DNA recombination at telomere [BP], nuclear migration along microfilament [BP], glycogen binding [MF]
CG_adsipsc_promoter_p_PM_12_240_7			3	0.6	1.59E-04	PANX1, VANGL2, OPRL1, GNAI1, IQGAP1	nociceptin receptor activity [MF], leak channel activity [MF], lateral plasma membrane [CC], adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway [BP]
CG_adsipsc_promoter_p_PM_12_438_18			1	0.2	6.46E-05	CORO1A, DNM1L	negative regulation of actin nucleation [BP], dynamin polymerization involved in mitochondrial fission [BP], membrane fission involved in mitochondrial fission [BP]
CG_adsipsc_promoter_p_PM_14_57_6			2	0.4	1.27E-05	HMCN1, CLSTN3, RET, MCTP2, PLS1	calcium ion binding [MF]
CG_adsipsc_promoter_p_PM_12_265_17			2	0.4	1.68E-05	SDHD, RIMS1, KANK1	negative regulation of lamellipodium morphogenesis [BP], calcium ion-dependent exocytosis of neurotransmitter [BP], negative regulation of ruffle assembly [BP], mitochondrial electron transport, succinate to ubiquinone [BP]
CG_adsipsc_promoter_p_PM_20_28_56			1	0.2	4.64E-05	PVR, CTNND1, CDH1	cell-cell adherens junction [CC], salivary gland morphogenesis [BP], cell adhesion molecule binding [MF], cell-cell junction organization [BP], adherens junction organization [BP], cell junction assembly [BP]
CG_adsipsc_promoter_p_PM_12_203_8			1	0.2	2.34E-05	HSD3B7, RNF4	cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF], progesterone receptor binding [MF], regulation of spindle assembly [BP], regulation of kinetochore assembly [BP]
CG_adsipsc_promoter_p_PM_18_9_30			4	0.8	6.11E-05	NF1, NR2E1	negative regulation of astrocyte differentiation [BP]
CG_adsipsc_promoter_p_PM_14_91_13			3	0.4	6.07E-05	MALSU1, NAGS, LGALS1	negative regulation of mitochondrial translation [BP], acetyl-CoA:L-glutamate N-acetyltransferase activity [MF], positive regulation of erythrocyte aggregation [BP]
CG_adsipsc_promoter_p_PM_18_8_35			4	0.8	3.30E-05	BBS9, DYNC2H1, BBS4, B3GNT4, DNAH2	galactosyltransferase activity [MF], ciliary or flagellar motility [BP], BBSome [CC]
CG_adsipsc_promoter_p_PM_18_13_52			4	0.8	2.68E-05	GLIS2, ZNF749, PAPD4, GNAI2, GGNBP2, SNRPE, ERBB2	RNA polymerase I core binding [MF], histone mRNA metabolic process [BP], nuclear RNA-directed RNA polymerase complex [CC], nucleus [CC]
CG_adsipsc_promoter_p_PM_12_372_17			3	0.6	7.73E-05	UAP1, AK4, KLHL41	tetracycline metabolic process [BP], regulation of lateral pseudopodium assembly [BP], UDP-N-acetylglucosamine diphosphorylase activity [MF], carbon tetrachloride metabolic process [BP]
CG_adsipsc_promoter_p_PM_12_495_15			2	0.4	1.52E-04	INSIG1	negative regulation of cargo loading into COPII-coated vesicle [BP]